| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 2.63e-08 | 11 | 182 | 5 | GO:0098973 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 1.38e-06 | 22 | 182 | 5 | GO:0050998 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | DCAF1 PRRX1 AKAP8 ACTB NSD1 REST SALL1 CTDP1 LRP2 HEY2 SMARCE1 TAF1 TAF1L HSPA4 PROX1 BRMS1 | 1.46e-06 | 417 | 182 | 16 | GO:0061629 |
| GeneOntologyMolecularFunction | transcription factor binding | DCAF1 PRRX1 ZBTB16 AKAP8 KAT6A ZBTB43 ACTB NSD1 REST HNRNPU SALL1 UBN1 CTDP1 LRP2 HEY2 SMARCE1 TAF1 TAF1L HSPA4 PROX1 BRMS1 | 5.44e-06 | 753 | 182 | 21 | GO:0008134 |
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 7.35e-06 | 5 | 182 | 3 | GO:0010856 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 9.82e-06 | 32 | 182 | 5 | GO:0099186 | |
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 1.46e-05 | 6 | 182 | 3 | GO:0031800 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | DCAF1 PRRX1 AKAP8 KAT6A ACTB NSD1 REST SALL1 CTDP1 LRP2 HEY2 SMARCE1 TAF1 TAF1L HSPA4 PROX1 BRMS1 | 2.51e-05 | 582 | 182 | 17 | GO:0140297 |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 3.65e-05 | 100 | 182 | 7 | GO:0019888 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 3.85e-05 | 42 | 182 | 5 | GO:0098918 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 6.01e-05 | 9 | 182 | 3 | GO:0010854 | |
| GeneOntologyMolecularFunction | RNA polymerase II core promoter sequence-specific DNA binding | 7.27e-05 | 25 | 182 | 4 | GO:0000979 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 7.98e-05 | 113 | 182 | 7 | GO:0019208 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 8.53e-05 | 10 | 182 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 9.95e-05 | 27 | 182 | 4 | GO:0001091 | |
| GeneOntologyMolecularFunction | chromatin binding | ZNF143 AKAP8 SMC1A KAT6A ACTB NSD1 CHD2 REST ADNP TTF1 HNRNPC HNRNPU SALL1 BRCA1 SMARCE1 TAF1 TAF1L CUX1 | 1.49e-04 | 739 | 182 | 18 | GO:0003682 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.92e-04 | 130 | 182 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | cyclase activator activity | 1.99e-04 | 13 | 182 | 3 | GO:0010853 | |
| GeneOntologyMolecularFunction | titin binding | 2.52e-04 | 14 | 182 | 3 | GO:0031432 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 2.94e-04 | 64 | 182 | 5 | GO:0140296 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 3.82e-04 | 16 | 182 | 3 | GO:0035256 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 3.82e-04 | 16 | 182 | 3 | GO:0008179 | |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 4.61e-04 | 17 | 182 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 5.49e-04 | 18 | 182 | 3 | GO:0010851 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 6.24e-04 | 43 | 182 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 6.24e-04 | 43 | 182 | 4 | GO:0043548 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 7.57e-04 | 20 | 182 | 3 | GO:0019211 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 8.11e-04 | 5 | 182 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.23e-03 | 229 | 182 | 8 | GO:0140993 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.23e-03 | 229 | 182 | 8 | GO:0003714 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 1.58e-03 | 55 | 182 | 4 | GO:0001046 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.67e-03 | 187 | 182 | 7 | GO:0016922 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 2.85e-03 | 9 | 182 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 3.10e-03 | 66 | 182 | 4 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 3.10e-03 | 66 | 182 | 4 | GO:0001098 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 2.84e-07 | 31 | 184 | 6 | GO:0098974 | |
| GeneOntologyBiologicalProcess | neuron projection development | ACSL6 PRRX1 NRDC TRIO USP9X POTEF CYTH2 ACTB APC ARFGEF1 MPDZ POTEKP REST INPP5F ADNP PTPN5 POTEE NEU1 SIPA1L1 ZNF335 ANAPC2 LRP2 PRKD1 FGFR2 PLD2 DMD POTEI NEXN CUX1 INPP5J RASAL1 | 3.81e-07 | 1285 | 184 | 31 | GO:0031175 |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 6.08e-07 | 35 | 184 | 6 | GO:0099188 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 6.98e-07 | 3 | 184 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | neuron development | ACSL6 PRRX1 NRDC TRIO USP9X POTEF CYTH2 ACTB APC ARFGEF1 MPDZ POTEKP REST INPP5F ADNP PTPN5 POTEE NEU1 SIPA1L1 ZNF335 ANAPC2 LRP2 PRKD1 GRIP2 FGFR2 PLD2 DMD POTEI NEXN CUX1 INPP5J RASAL1 | 2.03e-06 | 1463 | 184 | 32 | GO:0048666 |
| GeneOntologyBiologicalProcess | midbrain development | 2.53e-06 | 97 | 184 | 8 | GO:0030901 | |
| GeneOntologyBiologicalProcess | substantia nigra development | 2.83e-06 | 45 | 184 | 6 | GO:0021762 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 6.89e-06 | 5 | 184 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | DCAF1 SETD1B KAT6A ACTB NSD1 CHD2 REST TTF1 ASH2L HNRNPC HNRNPU UBN1 BRCA1 ATF7IP ZNF335 RLIM SMARCE1 TAF1 ATM TAF1L | 1.10e-05 | 741 | 184 | 20 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 1.37e-05 | 6 | 184 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 1.37e-05 | 6 | 184 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphorylation | NIBAN1 CALM1 CALM2 CALM3 ACTB APC WWTR1 INPP5F ADNP HNRNPU PWP1 DMD HSPA4 INPP5J | 1.55e-05 | 401 | 184 | 14 | GO:0042326 |
| GeneOntologyBiologicalProcess | chromatin organization | DCAF1 SETD1B KAT6A ACTB NSD1 CHD2 REST TTF1 ASH2L HNRNPC HNRNPU ZNF462 UBN1 BRCA1 ATF7IP ZNF335 RLIM HTATSF1 SMARCE1 TAF1 ATM TAF1L | 1.70e-05 | 896 | 184 | 22 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | DCAF1 SETD1B KAT6A ACTB NSD1 CHD2 REST TTF1 ASH2L HNRNPC HNRNPU ZNF462 UBN1 BRCA1 ATF7IP ZNF335 RLIM HEY2 HTATSF1 SMARCE1 TAF1 ATM TAF1L | 2.98e-05 | 999 | 184 | 23 | GO:0071824 |
| GeneOntologyBiologicalProcess | negative regulation of protein phosphorylation | NIBAN1 CALM1 CALM2 CALM3 ACTB APC WWTR1 INPP5F ADNP PWP1 DMD HSPA4 INPP5J | 3.38e-05 | 375 | 184 | 13 | GO:0001933 |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 3.78e-05 | 8 | 184 | 3 | GO:1901842 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 3.95e-05 | 22 | 184 | 4 | GO:0010881 | |
| GeneOntologyBiologicalProcess | neural nucleus development | 4.45e-05 | 72 | 184 | 6 | GO:0048857 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | SDE2 AKAP8 CALM1 CALM2 CALM3 USP28 ACTB APC WDR76 NEK1 BRCA1 ANAPC2 CTDP1 SMARCE1 TAF1 ATM PROX1 | 4.90e-05 | 627 | 184 | 17 | GO:0044770 |
| GeneOntologyBiologicalProcess | regulation of phosphatase activity | 5.20e-05 | 74 | 184 | 6 | GO:0010921 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 5.55e-05 | 237 | 184 | 10 | GO:0019827 | |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 5.64e-05 | 9 | 184 | 3 | GO:0060316 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | NRDC TRIO USP9X POTEF CNMD ACTB APC POTEKP REST ADNP POTEE SIPA1L1 ZNF335 ANAPC2 LRP2 PALM3 FGFR2 SCFD1 DMD POTEI NEXN CUX1 RASAL1 ARAP1 PROX1 | 6.23e-05 | 1194 | 184 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | maintenance of cell number | 6.60e-05 | 242 | 184 | 10 | GO:0098727 | |
| GeneOntologyBiologicalProcess | regulation of ryanodine-sensitive calcium-release channel activity | 7.86e-05 | 26 | 184 | 4 | GO:0060314 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphate metabolic process | NIBAN1 CALM1 CALM2 CALM3 ACTB APC WWTR1 INPP5F ADNP HNRNPU PWP1 DMD HSPA4 INPP5J | 1.04e-04 | 478 | 184 | 14 | GO:0045936 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | NRDC TRIO USP9X POTEF ACTB APC POTEKP ADNP POTEE SIPA1L1 ZNF335 ANAPC2 LRP2 FGFR2 DMD POTEI NEXN CUX1 RASAL1 | 1.06e-04 | 802 | 184 | 19 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 1.06e-04 | 28 | 184 | 4 | GO:0010882 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphorus metabolic process | NIBAN1 CALM1 CALM2 CALM3 ACTB APC WWTR1 INPP5F ADNP HNRNPU PWP1 DMD HSPA4 INPP5J | 1.09e-04 | 480 | 184 | 14 | GO:0010563 |
| GeneOntologyBiologicalProcess | negative regulation of ryanodine-sensitive calcium-release channel activity | 1.09e-04 | 11 | 184 | 3 | GO:0060315 | |
| GeneOntologyBiologicalProcess | positive regulation of protein autophosphorylation | 1.22e-04 | 29 | 184 | 4 | GO:0031954 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | NRDC TRIO USP9X POTEF ACTB APC POTEKP ADNP POTEE SIPA1L1 ZNF335 ANAPC2 LRP2 FGFR2 DMD POTEI NEXN CUX1 RASAL1 | 1.39e-04 | 819 | 184 | 19 | GO:0120039 |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 1.45e-04 | 12 | 184 | 3 | GO:1990034 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling involved in cardiac conduction | 1.45e-04 | 12 | 184 | 3 | GO:1901844 | |
| GeneOntologyBiologicalProcess | regulation of dephosphorylation | 1.53e-04 | 128 | 184 | 7 | GO:0035303 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | NRDC TRIO USP9X POTEF ACTB APC POTEKP ADNP POTEE SIPA1L1 ZNF335 ANAPC2 LRP2 FGFR2 DMD POTEI NEXN CUX1 RASAL1 | 1.55e-04 | 826 | 184 | 19 | GO:0048858 |
| GeneOntologyBiologicalProcess | axonogenesis | NRDC TRIO USP9X POTEF ACTB APC POTEKP ADNP POTEE SIPA1L1 ANAPC2 LRP2 FGFR2 POTEI NEXN | 1.77e-04 | 566 | 184 | 15 | GO:0007409 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-threonine phosphorylation | 1.81e-04 | 32 | 184 | 4 | GO:0010800 | |
| GeneOntologyBiologicalProcess | detection of calcium ion | 1.87e-04 | 13 | 184 | 3 | GO:0005513 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-serine phosphorylation | 2.05e-04 | 33 | 184 | 4 | GO:0033137 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 2.05e-04 | 33 | 184 | 4 | GO:0010880 | |
| GeneOntologyBiologicalProcess | negative regulation of protein modification process | NIBAN1 CALM1 CALM2 CALM3 ACTB APC WWTR1 INPP5F ADNP PWP1 TAF1 DMD HSPA4 INPP5J | 2.12e-04 | 512 | 184 | 14 | GO:0031400 |
| GeneOntologyBiologicalProcess | axon development | NRDC TRIO USP9X POTEF ACTB APC POTEKP INPP5F ADNP POTEE SIPA1L1 ANAPC2 LRP2 FGFR2 POTEI NEXN | 2.15e-04 | 642 | 184 | 16 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | 2.33e-04 | 137 | 184 | 7 | GO:0033135 | |
| GeneOntologyBiologicalProcess | dephosphorylation | CALM1 CALM2 CALM3 INPP5F PPP1R2 PTPN5 PPP1R2B CTDP1 CAMTA1 INPP5J PPP6R3 | 2.97e-04 | 347 | 184 | 11 | GO:0016311 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | DCAF1 CASP8AP2 ZNF536 PRRX1 ZBTB16 USP9X KAT6A NSD1 ZMYM2 GON4L WWTR1 REST HNRNPU SALL1 BRCA1 ATF7IP ZNF451 RLIM HEY2 SMARCE1 FGFR2 TAF1 CUX1 MXD1 PROX1 BRMS1 | 2.98e-04 | 1399 | 184 | 26 | GO:0045892 |
| GeneOntologyBiologicalProcess | regulation of organ growth | 3.02e-04 | 143 | 184 | 7 | GO:0046620 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 3.22e-04 | 37 | 184 | 4 | GO:0014808 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 3.43e-04 | 146 | 184 | 7 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | DCAF1 CASP8AP2 ZNF536 PRRX1 ZBTB16 USP9X KAT6A NSD1 ZMYM2 GON4L WWTR1 REST HNRNPU SALL1 BRCA1 ATF7IP ZNF451 RLIM HEY2 SMARCE1 FGFR2 TAF1 CUX1 MXD1 PROX1 BRMS1 | 3.47e-04 | 1413 | 184 | 26 | GO:1902679 |
| GeneOntologyBiologicalProcess | regulation of voltage-gated calcium channel activity | 3.57e-04 | 38 | 184 | 4 | GO:1901385 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 3.57e-04 | 147 | 184 | 7 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of high voltage-gated calcium channel activity | 3.59e-04 | 16 | 184 | 3 | GO:1901841 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | NIBAN1 CALM1 CALM2 CALM3 ACTB NSD1 APC MCM7 WWTR1 INPP5F ADNP HNRNPU ITPKB PPP1R2 PWP1 PTPN5 PPP1R2B TNKS1BP1 PRKD1 FGFR2 DMD CAMTA1 HSPA4 INPP5J PPP6R3 PROX1 | 3.78e-04 | 1421 | 184 | 26 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | NIBAN1 CALM1 CALM2 CALM3 ACTB NSD1 APC MCM7 WWTR1 INPP5F ADNP HNRNPU ITPKB PPP1R2 PWP1 PTPN5 PPP1R2B TNKS1BP1 PRKD1 FGFR2 DMD CAMTA1 HSPA4 INPP5J PPP6R3 PROX1 | 3.86e-04 | 1423 | 184 | 26 | GO:0051174 |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 3.88e-04 | 149 | 184 | 7 | GO:0051282 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 3.95e-04 | 39 | 184 | 4 | GO:1903514 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | NRDC TRIO USP9X POTEF ACTB APC POTEKP REST ADNP POTEE SIPA1L1 ANAPC2 LRP2 FGFR2 POTEI NEXN CUX1 | 3.99e-04 | 748 | 184 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | negative regulation of release of sequestered calcium ion into cytosol | 4.33e-04 | 17 | 184 | 3 | GO:0051280 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 4.55e-04 | 153 | 184 | 7 | GO:0051208 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol catabolic process | 4.69e-04 | 4 | 184 | 2 | GO:0031161 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 4.85e-04 | 111 | 184 | 6 | GO:0033045 | |
| GeneOntologyBiologicalProcess | protein dephosphorylation | 5.04e-04 | 256 | 184 | 9 | GO:0006470 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling | 5.16e-04 | 18 | 184 | 3 | GO:0010649 | |
| GeneOntologyBiologicalProcess | cell division | SDE2 ZBTB16 CALM1 TTC28 CALM2 CALM3 USP9X SMC1A APC WWTR1 HNRNPU NEK1 ANAPC2 CTDP1 FGFR2 NLRP5 | 5.32e-04 | 697 | 184 | 16 | GO:0051301 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH2 MYL1 STARD8 POTEF CYTH2 ACTB ARFGEF1 POTEKP POTEE CRACD SIPA1L1 PHACTR3 SCN8A TTC17 PRKD1 POTEI ARAP1 PROX1 NLRP5 | 5.33e-04 | 912 | 184 | 19 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | ANKK1 SDE2 CALM1 CALM2 CALM3 USP28 ACTB APC WDR76 HNRNPU NEK1 BRCA1 ANAPC2 SMARCE1 FGFR2 TAF1 ATM PROX1 | 5.79e-04 | 845 | 184 | 18 | GO:0010564 |
| GeneOntologyBiologicalProcess | regulation of DNA binding | 5.85e-04 | 115 | 184 | 6 | GO:0051101 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 5.85e-04 | 115 | 184 | 6 | GO:0018107 | |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 6.09e-04 | 19 | 184 | 3 | GO:0051284 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 6.30e-04 | 44 | 184 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | regulation of protein autophosphorylation | 7.47e-04 | 46 | 184 | 4 | GO:0031952 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 7.58e-04 | 217 | 184 | 8 | GO:0097553 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 7.58e-04 | 217 | 184 | 8 | GO:0000075 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 7.58e-04 | 217 | 184 | 8 | GO:0006941 | |
| GeneOntologyBiologicalProcess | negative regulation of voltage-gated calcium channel activity | 8.25e-04 | 21 | 184 | 3 | GO:1901386 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 9.06e-04 | 125 | 184 | 6 | GO:0018210 | |
| GeneOntologyBiologicalProcess | dosage compensation by inactivation of X chromosome | 9.49e-04 | 22 | 184 | 3 | GO:0009048 | |
| GeneOntologyBiologicalProcess | DNA damage response | SDE2 USP28 USP9X SMC1A ACTB APC MCM7 CHD2 WDR76 ASH2L NEK1 UBA1 BRCA1 HTATSF1 SMARCE1 TNKS1BP1 BOD1L1 TAF1 ATM | 9.70e-04 | 959 | 184 | 19 | GO:0006974 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 1.04e-03 | 228 | 184 | 8 | GO:0046777 | |
| GeneOntologyBiologicalProcess | cell cycle process | ANKK1 SDE2 AKAP8 CALM1 CALM2 CALM3 USP28 USP9X SMC1A ACTB APC MCM7 WDR76 HNRNPU NEK1 BRCA1 CEP72 ANAPC2 CTDP1 SMARCE1 FGFR2 TAF1 ATM PROX1 NLRP5 | 1.06e-03 | 1441 | 184 | 25 | GO:0022402 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.09e-03 | 87 | 184 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 1.10e-03 | 51 | 184 | 4 | GO:1902459 | |
| GeneOntologyBiologicalProcess | pulmonary artery morphogenesis | 1.16e-03 | 6 | 184 | 2 | GO:0061156 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-threonine phosphorylation | 1.19e-03 | 52 | 184 | 4 | GO:0010799 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle checkpoint | 1.19e-03 | 52 | 184 | 4 | GO:1901976 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | DCAF1 ZNF536 PRRX1 ZBTB16 USP9X NSD1 WWTR1 REST HNRNPU SALL1 ATF7IP ZNF451 RLIM HEY2 FGFR2 TAF1 CUX1 MXD1 PROX1 BRMS1 | 1.19e-03 | 1053 | 184 | 20 | GO:0000122 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | ACSL6 PRRX1 NRDC CYTH2 INPP5F ADNP PTPN5 NEU1 SIPA1L1 ANAPC2 PRKD1 DMD CUX1 INPP5J | 1.22e-03 | 612 | 184 | 14 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of DNA damage checkpoint | 1.23e-03 | 24 | 184 | 3 | GO:2000001 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 1.23e-03 | 24 | 184 | 3 | GO:0010801 | |
| GeneOntologyBiologicalProcess | sex-chromosome dosage compensation | 1.23e-03 | 24 | 184 | 3 | GO:0007549 | |
| GeneOntologyBiologicalProcess | negative regulation of organ growth | 1.28e-03 | 53 | 184 | 4 | GO:0046621 | |
| GeneOntologyBiologicalProcess | muscle system process | MYH2 MYL1 CALM1 CALM2 SYNM CALM3 INPP5F CTDP1 SCN8A HEY2 PRKD1 GRIP2 DMD | 1.30e-03 | 547 | 184 | 13 | GO:0003012 |
| GeneOntologyBiologicalProcess | ventricular septum development | 1.34e-03 | 91 | 184 | 5 | GO:0003281 | |
| GeneOntologyBiologicalProcess | DNA damage checkpoint signaling | 1.40e-03 | 136 | 184 | 6 | GO:0000077 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | NIBAN1 CALM1 CALM2 CALM3 ACTB NSD1 APC MCM7 WWTR1 INPP5F ADNP HNRNPU ITPKB PWP1 PTPN5 TNKS1BP1 PRKD1 FGFR2 DMD HSPA4 INPP5J PROX1 | 1.40e-03 | 1226 | 184 | 22 | GO:0042325 |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.41e-03 | 92 | 184 | 5 | GO:0048844 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | APC ARFGEF1 HNRNPC HNRNPU CRACD BRCA1 FGFR2 ATM SCFD1 INPP5J ARAP1 | 1.45e-03 | 421 | 184 | 11 | GO:0010639 |
| GeneOntologyCellularComponent | axon | CALM1 CALM2 CALM3 USP9X POTEF CYTH2 ACTB CPLX1 APC POTEKP INPP5F ADNP ITPR2 PPP1R2 PTPN5 POTEE PPP1R2B CLCN3 CPLX3 SCN8A LRP2 DMD POTEI NEXN INPP5J | 2.74e-07 | 891 | 183 | 25 | GO:0030424 |
| GeneOntologyCellularComponent | chromatin | PRRX1 ZNF143 AKAP8 POTEF KAT6A ZBTB43 ACTB NSD1 GON4L MCM7 CHD2 POTEKP REST RFX7 WDR76 ADNP ASH2L HNRNPC POTEE UBA1 SALL1 ZFHX4 HEY2 SMARCE1 TNKS1BP1 TAF1 POTEI TAF1L CUX1 MXD1 PROX1 BRMS1 | 1.73e-06 | 1480 | 183 | 32 | GO:0000785 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 4.22e-06 | 75 | 183 | 7 | GO:0035097 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 8.09e-06 | 32 | 183 | 5 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 8.09e-06 | 32 | 183 | 5 | GO:0043189 | |
| GeneOntologyCellularComponent | sarcomere | 1.29e-05 | 249 | 183 | 11 | GO:0030017 | |
| GeneOntologyCellularComponent | calyx of Held | 1.47e-05 | 36 | 183 | 5 | GO:0044305 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 2.25e-05 | 7 | 183 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 2.93e-05 | 179 | 183 | 9 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 2.93e-05 | 179 | 183 | 9 | GO:0030672 | |
| GeneOntologyCellularComponent | myofibril | 3.02e-05 | 273 | 183 | 11 | GO:0030016 | |
| GeneOntologyCellularComponent | distal axon | CALM1 CALM2 CALM3 USP9X CYTH2 ACTB CPLX1 APC PPP1R2 PPP1R2B CLCN3 CPLX3 LRP2 INPP5J | 3.10e-05 | 435 | 183 | 14 | GO:0150034 |
| GeneOntologyCellularComponent | nuclear matrix | 3.31e-05 | 140 | 183 | 8 | GO:0016363 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 4.48e-05 | 45 | 183 | 5 | GO:1902562 | |
| GeneOntologyCellularComponent | methyltransferase complex | 4.65e-05 | 108 | 183 | 7 | GO:0034708 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 5.23e-05 | 290 | 183 | 11 | GO:0043292 | |
| GeneOntologyCellularComponent | growth cone | CALM1 CALM2 CALM3 USP9X CYTH2 APC PPP1R2 PPP1R2B LRP2 INPP5J | 6.26e-05 | 245 | 183 | 10 | GO:0030426 |
| GeneOntologyCellularComponent | apical junction complex | 7.80e-05 | 158 | 183 | 8 | GO:0043296 | |
| GeneOntologyCellularComponent | site of polarized growth | CALM1 CALM2 CALM3 USP9X CYTH2 APC PPP1R2 PPP1R2B LRP2 INPP5J | 8.18e-05 | 253 | 183 | 10 | GO:0030427 |
| GeneOntologyCellularComponent | spindle pole | 8.41e-05 | 205 | 183 | 9 | GO:0000922 | |
| GeneOntologyCellularComponent | pronucleus | 9.87e-05 | 28 | 183 | 4 | GO:0045120 | |
| GeneOntologyCellularComponent | late endosome lumen | 1.03e-04 | 11 | 183 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | exocytic vesicle | 1.25e-04 | 320 | 183 | 11 | GO:0070382 | |
| GeneOntologyCellularComponent | nuclear periphery | 1.35e-04 | 171 | 183 | 8 | GO:0034399 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | DCAF1 ZNF143 SETD1B ACTB NSD1 ARFGEF1 NOL11 GON4L MCM7 ADNP ASH2L HNRNPC HNRNPU SALL1 BRCA1 CD2BP2 ZNF335 ANAPC2 HTATSF1 SMARCE1 BOD1L1 TAF1 CPSF2 TAF1L MXD1 BRMS1 | 1.73e-04 | 1377 | 183 | 26 | GO:0140513 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.78e-04 | 94 | 183 | 6 | GO:0000123 | |
| GeneOntologyCellularComponent | neuron projection terminus | 2.21e-04 | 233 | 183 | 9 | GO:0044306 | |
| GeneOntologyCellularComponent | tight junction | 2.27e-04 | 139 | 183 | 7 | GO:0070160 | |
| GeneOntologyCellularComponent | cell-cell junction | MAGI1 JCAD MYH2 SYNM CYTH2 FBF1 ACTB APC MPDZ UBA1 UBN1 NHS TNKS1BP1 PRKD1 NEXN | 2.30e-04 | 591 | 183 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 3.09e-04 | 104 | 183 | 6 | GO:0031248 | |
| GeneOntologyCellularComponent | synaptic vesicle | 3.25e-04 | 300 | 183 | 10 | GO:0008021 | |
| GeneOntologyCellularComponent | Set1C/COMPASS complex | 3.40e-04 | 16 | 183 | 3 | GO:0048188 | |
| GeneOntologyCellularComponent | nuclear body | CASP8AP2 SDE2 ZBTB16 SETD1B LPAR4 USP28 KAT6A ZMYM2 GON4L WWTR1 PHAX HNRNPU UBN1 BRCA1 ATF7IP ZNF451 CD2BP2 NHS DNAAF1 | 3.75e-04 | 903 | 183 | 19 | GO:0016604 |
| GeneOntologyCellularComponent | acetyltransferase complex | 3.98e-04 | 109 | 183 | 6 | GO:1902493 | |
| GeneOntologyCellularComponent | centrosome | CCDC14 CLUAP1 CALM1 TTC28 CALM2 CALM3 USP9X FBF1 APC ANKRD62 HNRNPU NEK1 UBN1 BRCA1 CEP72 CTDP1 ATM | 4.48e-04 | 770 | 183 | 17 | GO:0005813 |
| GeneOntologyCellularComponent | endosome lumen | 5.37e-04 | 43 | 183 | 4 | GO:0031904 | |
| GeneOntologyCellularComponent | adherens junction | 5.76e-04 | 212 | 183 | 8 | GO:0005912 | |
| GeneOntologyCellularComponent | PML body | 8.22e-04 | 125 | 183 | 6 | GO:0016605 | |
| GeneOntologyCellularComponent | transcription repressor complex | 1.01e-03 | 87 | 183 | 5 | GO:0017053 | |
| GeneOntologyCellularComponent | bicellular tight junction | 1.05e-03 | 131 | 183 | 6 | GO:0005923 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 1.15e-03 | 293 | 183 | 9 | GO:0030658 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH2 DNAH3 MYL1 CALM1 CALM2 SYNM CALM3 POTEF FBF1 ACTB APC POTEKP HNRNPU POTEE RTL1 SCN8A PRKD1 DMD POTEI DNAH5 NEXN | 1.57e-03 | 1179 | 183 | 21 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH2 DNAH3 MYL1 CALM1 CALM2 SYNM CALM3 POTEF FBF1 ACTB APC POTEKP HNRNPU POTEE RTL1 SCN8A PRKD1 DMD POTEI DNAH5 NEXN | 1.71e-03 | 1187 | 183 | 21 | GO:0099081 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH2 MYL1 POTEF ACTB ANKRD62 POTEKP HNRNPC POTEE TRMT10A SIPA1L1 TTC17 POTEI NEXN | 1.74e-03 | 576 | 183 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | nuclear chromosome | 1.83e-03 | 254 | 183 | 8 | GO:0000228 | |
| GeneOntologyCellularComponent | presynapse | PRUNE2 DMXL2 CALM1 TRIO CALM2 CALM3 ACTB CPLX1 APC PTPN5 STXBP2 CLCN3 CPLX3 SCN8A ATM PLD2 DMD | 2.06e-03 | 886 | 183 | 17 | GO:0098793 |
| GeneOntologyCellularComponent | transport vesicle | DMXL2 CALM1 CALM2 CALM3 SYTL2 APC BGN PTPN5 CLCN3 CPLX3 ATM DMD | 2.13e-03 | 519 | 183 | 12 | GO:0030133 |
| GeneOntologyCellularComponent | Z disc | 2.17e-03 | 151 | 183 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | transcription regulator complex | ZNF143 ZBTB16 WWTR1 REST ADNP HNRNPU SALL1 ATF7IP RLIM HEY2 TAF1 TAF1L MXD1 | 2.34e-03 | 596 | 183 | 13 | GO:0005667 |
| GeneOntologyCellularComponent | sperm midpiece | 2.40e-03 | 64 | 183 | 4 | GO:0097225 | |
| GeneOntologyCellularComponent | axon terminus | 2.56e-03 | 210 | 183 | 7 | GO:0043679 | |
| GeneOntologyCellularComponent | migrasome | 2.64e-03 | 9 | 183 | 2 | GO:0140494 | |
| GeneOntologyCellularComponent | MLL1 complex | 2.72e-03 | 32 | 183 | 3 | GO:0071339 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 2.97e-03 | 33 | 183 | 3 | GO:0044665 | |
| GeneOntologyCellularComponent | microtubule organizing center | CCDC14 CLUAP1 CALM1 TTC28 CALM2 CALM3 USP9X FBF1 APC ANKRD62 HNRNPU NEK1 UBN1 BRCA1 CEP72 CTDP1 ATM | 3.01e-03 | 919 | 183 | 17 | GO:0005815 |
| GeneOntologyCellularComponent | bBAF complex | 3.28e-03 | 10 | 183 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | I band | 3.47e-03 | 166 | 183 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | dendrite | NRDC CPLX1 APC MPDZ INPP5F ADNP RGS12 HNRNPU PPP1R2 PTPN5 PPP1R2B SIPA1L1 SCN8A LRP2 GRIP2 INPP5J | 3.67e-03 | 858 | 183 | 16 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | NRDC CPLX1 APC MPDZ INPP5F ADNP RGS12 HNRNPU PPP1R2 PTPN5 PPP1R2B SIPA1L1 SCN8A LRP2 GRIP2 INPP5J | 3.75e-03 | 860 | 183 | 16 | GO:0097447 |
| GeneOntologyCellularComponent | spindle midzone | 5.14e-03 | 40 | 183 | 3 | GO:0051233 | |
| GeneOntologyCellularComponent | anchoring junction | MAGI1 JCAD MYH2 STARD8 SYNM CYTH2 FBF1 ACTB APC MPDZ UBA1 UBN1 NHS TNKS1BP1 PRKD1 DMD NEXN | 5.47e-03 | 976 | 183 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | condensed chromosome | 5.78e-03 | 307 | 183 | 8 | GO:0000793 | |
| GeneOntologyCellularComponent | npBAF complex | 6.47e-03 | 14 | 183 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 6.47e-03 | 14 | 183 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | spindle microtubule | 6.91e-03 | 86 | 183 | 4 | GO:0005876 | |
| HumanPheno | Downslanted palpebral fissures | TSR2 DMXL2 PRRX1 SETD1B TRIO USP9X SMC1A ACTB CPLX1 NSD1 APC ZMYM2 MPDZ ADNP HNRNPC BGN ZNF462 TRMT10A CLCN3 RLIM SCN8A LRP2 FGFR2 TAF1 CAMTA1 | 4.12e-09 | 497 | 71 | 25 | HP:0000494 |
| HumanPheno | Abnormality of the palpebral fissures | TSR2 DMXL2 PRRX1 SETD1B TRIO USP9X SMC1A ACTB CPLX1 NSD1 APC ZMYM2 MPDZ MCM7 RFX7 ADNP HNRNPC HNRNPU BGN ZNF462 TRMT10A SALL1 CLCN3 BRCA1 RTL1 RLIM SCN8A LRP2 FGFR2 TAF1 CAMTA1 CUX1 | 3.90e-08 | 880 | 71 | 32 | HP:0008050 |
| HumanPheno | Slanting of the palpebral fissure | TSR2 DMXL2 PRRX1 SETD1B TRIO USP9X SMC1A ACTB CPLX1 NSD1 APC ZMYM2 MPDZ MCM7 RFX7 ADNP HNRNPC HNRNPU BGN ZNF462 TRMT10A CLCN3 BRCA1 RLIM SCN8A LRP2 FGFR2 TAF1 CAMTA1 | 4.56e-08 | 739 | 71 | 29 | HP:0200006 |
| HumanPheno | Thin upper lip vermilion | TRIO USP9X SMC1A KAT6A ACTB CPLX1 APC MCM7 CHD2 RFX7 ADNP HNRNPC TRMT10A CLCN3 BRCA1 SMARCE1 FGFR2 TAF1 CUX1 | 9.41e-08 | 339 | 71 | 19 | HP:0000219 |
| HumanPheno | Thin lips | TRIO USP9X SMC1A KAT6A ACTB CPLX1 APC MCM7 CHD2 RFX7 ADNP HNRNPC TRMT10A CLCN3 BRCA1 SMARCE1 FGFR2 TAF1 CUX1 | 9.41e-08 | 339 | 71 | 19 | HP:0000213 |
| HumanPheno | Abnormality of upper lip vermillion | TRIO USP9X SMC1A KAT6A ACTB CPLX1 APC MCM7 CHD2 RFX7 ADNP HNRNPC HNRNPU ZNF462 TRMT10A CLCN3 BRCA1 RTL1 SMARCE1 FGFR2 TAF1 CUX1 | 1.42e-07 | 464 | 71 | 22 | HP:0011339 |
| HumanPheno | Thin vermilion border | TRIO USP9X SMC1A KAT6A ACTB CPLX1 APC MCM7 CHD2 RFX7 ADNP HNRNPC HNRNPU TRMT10A CLCN3 BRCA1 SMARCE1 FGFR2 TAF1 CAMTA1 CUX1 | 2.03e-07 | 433 | 71 | 21 | HP:0000233 |
| HumanPheno | Abnormal nostril morphology | DMXL2 PRRX1 TRIO SMC1A KAT6A ACTB NSD1 APC ZMYM2 CHD2 RFX7 ADNP ZNF462 NEK1 TRMT10A BRCA1 RTL1 LRP2 SMARCE1 PLCB3 PRKD1 FGFR2 TAF1 CAMTA1 | 3.56e-07 | 575 | 71 | 24 | HP:0005288 |
| HumanPheno | Abnormal nasal tip morphology | TRIO USP9X KAT6A ACTB CPLX1 NSD1 APC ZMYM2 MPDZ RFX7 ADNP ZNF462 NEK1 CLCN3 LRP2 SMARCE1 TAF1 CAMTA1 CUX1 | 7.27e-07 | 386 | 71 | 19 | HP:0000436 |
| HumanPheno | Anteverted nares | DMXL2 TRIO SMC1A KAT6A ACTB NSD1 APC ZMYM2 CHD2 RFX7 ADNP ZNF462 NEK1 TRMT10A BRCA1 RTL1 LRP2 SMARCE1 PLCB3 PRKD1 FGFR2 TAF1 CAMTA1 | 8.90e-07 | 559 | 71 | 23 | HP:0000463 |
| HumanPheno | Upturned nose | DMXL2 TRIO SMC1A KAT6A ACTB NSD1 APC ZMYM2 CHD2 RFX7 ADNP ZNF462 NEK1 TRMT10A BRCA1 RTL1 LRP2 SMARCE1 PLCB3 PRKD1 FGFR2 TAF1 CAMTA1 | 8.90e-07 | 559 | 71 | 23 | HP:0000427 |
| HumanPheno | Broad finger | DMXL2 USP9X NSD1 ADNP BGN NEK1 SALL1 RTL1 RLIM NHS PRKD1 FGFR2 | 1.04e-06 | 154 | 71 | 12 | HP:0001500 |
| HumanPheno | Abnormal morphology of the nasal alae | DMXL2 TRIO USP9X SMC1A KAT6A ACTB NSD1 APC ZMYM2 CHD2 RFX7 ADNP ZNF462 NEK1 TRMT10A BRCA1 RTL1 LRP2 SMARCE1 PLCB3 PRKD1 FGFR2 TAF1 CAMTA1 | 2.50e-06 | 639 | 71 | 24 | HP:0000429 |
| HumanPheno | Abnormality of thumb phalanx | TSR2 TRIO USP9X SMC1A ACTB NSD1 ADNP SALL1 BRCA1 RTL1 RLIM PRKD1 FGFR2 | 3.66e-06 | 205 | 71 | 13 | HP:0009602 |
| HumanPheno | Brachydactyly (hand) | TSR2 DMXL2 TRIO USP9X SMC1A CPLX1 NSD1 APC ZMYM2 ADNP BGN NEK1 SALL1 RTL1 RLIM NHS SMARCE1 PRKD1 FGFR2 | 3.75e-06 | 430 | 71 | 19 | HP:0100667 |
| HumanPheno | Abnormality of globe location or size | TSR2 PRRX1 TRIO USP9X SMC1A KAT6A ACTB CPLX1 NSD1 APC ZMYM2 CHD2 ADNP HNRNPC HNRNPU BGN ZNF462 NEK1 TRMT10A SALL1 CLCN3 BRCA1 CDCA7 RTL1 RLIM CTDP1 LRP2 HEY2 NHS SMARCE1 PLCB3 FGFR2 TAF1 CAMTA1 CUX1 | 4.45e-06 | 1246 | 71 | 35 | HP:0000489 |
| HumanPheno | Abnormal external nose morphology | DMXL2 TRIO USP9X SMC1A KAT6A ACTB CPLX1 NSD1 APC ZMYM2 MPDZ CHD2 RFX7 ADNP ZNF462 NEK1 TRMT10A CLCN3 BRCA1 RTL1 RLIM LRP2 SMARCE1 PLCB3 PRKD1 FGFR2 TAF1 CAMTA1 CUX1 | 4.89e-06 | 916 | 71 | 29 | HP:0010938 |
| HumanPheno | Broad phalanx | 4.91e-06 | 148 | 71 | 11 | HP:0006009 | |
| HumanPheno | Broad phalanges of the hand | 4.91e-06 | 148 | 71 | 11 | HP:0009768 | |
| HumanPheno | Triangular shaped phalanges of the hand | TSR2 TRIO USP9X SMC1A ACTB NSD1 ADNP SALL1 BRCA1 RTL1 RLIM PRKD1 FGFR2 | 5.90e-06 | 214 | 71 | 13 | HP:0009774 |
| HumanPheno | Abnormality of the frontal hairline | TSR2 TRIO SMC1A CPLX1 NSD1 ADNP TRMT10A CLCN3 BRCA1 LRP2 SMARCE1 PRKD1 FGFR2 | 6.22e-06 | 215 | 71 | 13 | HP:0000599 |
| HumanPheno | Abnormality of the forehead | TSR2 DMXL2 TRIO USP9X SMC1A KAT6A ACTB CPLX1 NSD1 APC MPDZ MCM7 CHD2 RFX7 ADNP HNRNPU BGN ZNF462 TRMT10A NEU1 GET4 CLCN3 BRCA1 RTL1 ZNF335 RLIM SCN8A LRP2 SMARCE1 PRKD1 FGFR2 TAF1 CAMTA1 CUX1 | 6.61e-06 | 1208 | 71 | 34 | HP:0000290 |
| HumanPheno | Congenital abnormal hair pattern | TSR2 TRIO SMC1A ACTB CPLX1 NSD1 APC ADNP TRMT10A CLCN3 BRCA1 LRP2 SMARCE1 PRKD1 FGFR2 CAMTA1 | 7.20e-06 | 327 | 71 | 16 | HP:0011361 |
| HumanPheno | Abnormal thumb morphology | TSR2 TRIO USP9X SMC1A ACTB CPLX1 NSD1 APC ZMYM2 ADNP ZNF462 NEK1 SALL1 BRCA1 RTL1 RLIM PRKD1 FGFR2 | 7.39e-06 | 408 | 71 | 18 | HP:0001172 |
| HumanPheno | Abnormal facial shape | SETD1B TRIO USP9X SMC1A KAT6A ACTB CPLX1 NSD1 APC ZMYM2 MPDZ CHD2 RFX7 ADNP HNRNPC BGN NEK1 TRMT10A UBA1 NEU1 SALL1 CLCN3 BRCA1 CDCA7 RTL1 RLIM CTDP1 LRP2 NHS SMARCE1 FGFR2 TAF1 CAMTA1 CUX1 | 8.49e-06 | 1221 | 71 | 34 | HP:0001999 |
| HumanPheno | Broad long bones | 8.71e-06 | 157 | 71 | 11 | HP:0005622 | |
| HumanPheno | Abnormality of the hairline | TSR2 TRIO SMC1A ACTB CPLX1 NSD1 APC ADNP TRMT10A CLCN3 BRCA1 LRP2 SMARCE1 PRKD1 FGFR2 | 8.87e-06 | 294 | 71 | 15 | HP:0009553 |
| HumanPheno | Abnormal cardiac septum morphology | TSR2 DMXL2 PRRX1 TRIO CALM3 USP9X SMC1A KAT6A CPLX1 NSD1 ZMYM2 MPDZ RFX7 ADNP HNRNPU ZNF462 NEK1 SALL1 CLCN3 BRCA1 RTL1 LRP2 SMARCE1 PRKD1 FGFR2 CUX1 | 9.10e-06 | 787 | 71 | 26 | HP:0001671 |
| HumanPheno | Broad nasal tip | 9.83e-06 | 159 | 71 | 11 | HP:0000455 | |
| HumanPheno | Delayed speech and language development | SETD1B TRIO USP9X SMC1A KAT6A CPLX1 NSD1 ARFGEF1 ZMYM2 CHD2 RFX7 ADNP HNRNPC HNRNPU ZNF462 NEK1 GET4 CLCN3 BRCA1 RTL1 NEMF RLIM SCN8A SMARCE1 PRKD1 TAF1 ATM DMD CAMTA1 DNAAF1 DNAH5 CUX1 | 1.18e-05 | 1123 | 71 | 32 | HP:0000750 |
| HumanPheno | Abnormal umbilicus morphology | TPO DMXL2 KAT6A ACTB NSD1 RFX7 ADNP BGN NEU1 SALL1 BRCA1 CDCA7 RTL1 LRP2 FGFR2 | 1.89e-05 | 313 | 71 | 15 | HP:0001551 |
| HumanPheno | Abnormal hair pattern | TSR2 TRIO USP9X SMC1A ACTB CPLX1 NSD1 APC CHD2 ADNP HNRNPU BGN TRMT10A NEU1 CLCN3 BRCA1 RTL1 LRP2 SMARCE1 PRKD1 FGFR2 TAF1 CAMTA1 | 2.34e-05 | 676 | 71 | 23 | HP:0010720 |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | DMXL2 TRIO USP9X SMC1A NSD1 ADNP BGN NEK1 SALL1 RTL1 RLIM NHS SMARCE1 PRKD1 FGFR2 | 2.37e-05 | 319 | 71 | 15 | HP:0009767 |
| HumanPheno | Abnormal eyelid morphology | TSR2 DMXL2 PRRX1 SETD1B TRIO USP9X SMC1A KAT6A ACTB CPLX1 NSD1 APC ZMYM2 MPDZ MCM7 RFX7 ADNP HNRNPC HNRNPU BGN ZNF462 NEK1 TRMT10A SALL1 CLCN3 BRCA1 CDCA7 RTL1 RLIM SCN8A LRP2 SMARCE1 FGFR2 TAF1 CAMTA1 CUX1 | 2.84e-05 | 1408 | 71 | 36 | HP:0000492 |
| HumanPheno | Agenesis of corpus callosum | PRRX1 SMC1A ACTB CPLX1 NSD1 MPDZ MCM7 HNRNPU ZNF462 GET4 SALL1 CLCN3 ZNF335 LRP2 SMARCE1 FGFR2 | 2.89e-05 | 365 | 71 | 16 | HP:0001274 |
| HumanPheno | Intellectual disability, mild | SETD1B TRIO SMC1A ACTB CPLX1 NSD1 APC ZMYM2 HNRNPC ZNF462 RTL1 CTDP1 SCN8A FGFR2 DMD CAMTA1 | 2.89e-05 | 365 | 71 | 16 | HP:0001256 |
| HumanPheno | Hernia | TPO DMXL2 SMC1A ACTB CPLX1 NSD1 RFX7 ADNP BGN UBA1 NEU1 SALL1 BRCA1 CDCA7 RTL1 RLIM LRP2 HEY2 SMARCE1 FGFR2 CAMTA1 | 2.99e-05 | 589 | 71 | 21 | HP:0100790 |
| HumanPheno | Abnormality of external features of the abdomen | TPO DMXL2 KAT6A ACTB NSD1 RFX7 ADNP BGN NEU1 SALL1 BRCA1 CDCA7 RTL1 LRP2 FGFR2 | 3.07e-05 | 326 | 71 | 15 | HP:0001462 |
| HumanPheno | Language impairment | SETD1B TRIO USP9X SMC1A KAT6A CPLX1 NSD1 ARFGEF1 ZMYM2 CHD2 RFX7 ADNP HNRNPC HNRNPU ZNF462 NEK1 GET4 CLCN3 BRCA1 RTL1 NEMF RLIM SCN8A SMARCE1 PRKD1 TAF1 ATM DMD CAMTA1 DNAAF1 DNAH5 CUX1 | 3.33e-05 | 1178 | 71 | 32 | HP:0002463 |
| HumanPheno | Abnormality of globe location | TSR2 PRRX1 TRIO USP9X SMC1A KAT6A ACTB CPLX1 NSD1 APC ZMYM2 ADNP HNRNPC HNRNPU BGN ZNF462 NEK1 TRMT10A CLCN3 BRCA1 CDCA7 RTL1 RLIM LRP2 HEY2 SMARCE1 PLCB3 FGFR2 TAF1 CAMTA1 CUX1 | 3.44e-05 | 1122 | 71 | 31 | HP:0100886 |
| HumanPheno | Flared metaphysis | 5.51e-05 | 191 | 71 | 11 | HP:0003015 | |
| HumanPheno | Abnormal sternum morphology | TRIO SMC1A KAT6A ACTB CPLX1 NSD1 REST ADNP BGN NEK1 TRMT10A NEU1 RTL1 LRP2 HEY2 FGFR2 TAF1 CUX1 | 5.75e-05 | 474 | 71 | 18 | HP:0000766 |
| HumanPheno | Abnormal cardiac atrium morphology | TSR2 PRRX1 TRIO USP9X SMC1A KAT6A CPLX1 NSD1 ZMYM2 MPDZ ADNP NEK1 SALL1 CLCN3 BRCA1 RTL1 SMARCE1 FGFR2 DNAAF1 DNAH5 CUX1 | 6.03e-05 | 617 | 71 | 21 | HP:0005120 |
| HumanPheno | Umbilical hernia | TPO DMXL2 ACTB NSD1 RFX7 ADNP BGN NEU1 SALL1 BRCA1 CDCA7 RTL1 LRP2 FGFR2 | 6.29e-05 | 306 | 71 | 14 | HP:0001537 |
| HumanPheno | Short phalanx of finger | DMXL2 USP9X SMC1A NSD1 ADNP BGN NEK1 SALL1 RTL1 RLIM NHS SMARCE1 PRKD1 FGFR2 | 6.29e-05 | 306 | 71 | 14 | HP:0009803 |
| HumanPheno | Short digit | TSR2 DMXL2 TRIO USP9X SMC1A KAT6A CPLX1 NSD1 APC ZMYM2 ADNP BGN NEK1 SALL1 RTL1 RLIM NHS SMARCE1 PLCB3 PRKD1 FGFR2 TAF1 | 6.87e-05 | 672 | 71 | 22 | HP:0011927 |
| HumanPheno | Abnormal morphology of bones of the upper limbs | DMXL2 TRIO USP9X SMC1A CPLX1 NSD1 APC ADNP BGN NEK1 SALL1 BRCA1 RTL1 RLIM NHS PRKD1 FGFR2 | 6.99e-05 | 436 | 71 | 17 | HP:0040065 |
| HumanPheno | Metaphyseal widening | DMXL2 USP9X NSD1 ADNP BGN NEK1 SALL1 RTL1 RLIM PLCB3 PRKD1 FGFR2 | 7.02e-05 | 232 | 71 | 12 | HP:0003016 |
| HumanPheno | Abnormal upper limb bone morphology | DMXL2 TRIO USP9X SMC1A CPLX1 NSD1 APC ADNP BGN NEK1 SALL1 CLCN3 BRCA1 RTL1 RLIM NHS PRKD1 FGFR2 | 7.58e-05 | 484 | 71 | 18 | HP:0040070 |
| HumanPheno | Dysplastic corpus callosum | PRRX1 SMC1A ACTB CPLX1 NSD1 MPDZ MCM7 HNRNPU ZNF462 GET4 SALL1 CLCN3 ZNF335 LRP2 SMARCE1 FGFR2 | 7.60e-05 | 395 | 71 | 16 | HP:0006989 |
| HumanPheno | Aplasia/Hypoplasia involving the nose | PRRX1 TRIO SMC1A ACTB APC ZMYM2 RFX7 ADNP ZNF462 TRMT10A BRCA1 CDCA7 LRP2 SMARCE1 PLCB3 FGFR2 | 9.11e-05 | 401 | 71 | 16 | HP:0009924 |
| HumanPheno | Atrial septal defect | TSR2 PRRX1 TRIO USP9X SMC1A KAT6A CPLX1 NSD1 ZMYM2 MPDZ ADNP NEK1 SALL1 CLCN3 BRCA1 RTL1 SMARCE1 FGFR2 CUX1 | 9.93e-05 | 541 | 71 | 19 | HP:0001631 |
| HumanPheno | Abnormality of the atrial septum | TSR2 PRRX1 TRIO USP9X SMC1A KAT6A CPLX1 NSD1 ZMYM2 MPDZ ADNP NEK1 SALL1 CLCN3 BRCA1 RTL1 SMARCE1 FGFR2 CUX1 | 9.93e-05 | 541 | 71 | 19 | HP:0001630 |
| HumanPheno | High palate | TSR2 MYH2 DMXL2 MYL1 TRIO USP9X SMC1A ACTB NSD1 APC ZMYM2 RFX7 ADNP HNRNPU BGN NEK1 UBA1 CLCN3 BRCA1 RTL1 HEY2 FGFR2 TAF1 CAMTA1 | 1.04e-04 | 794 | 71 | 24 | HP:0000218 |
| HumanPheno | Abnormal atrial septum morphology | TSR2 PRRX1 TRIO USP9X SMC1A KAT6A CPLX1 NSD1 ZMYM2 MPDZ ADNP NEK1 SALL1 CLCN3 BRCA1 RTL1 SMARCE1 FGFR2 CUX1 | 1.07e-04 | 544 | 71 | 19 | HP:0011994 |
| HumanPheno | Toe syndactyly | TRIO SMC1A KAT6A NSD1 APC ADNP NEK1 SALL1 BRCA1 PRKD1 FGFR2 CAMTA1 | 1.14e-04 | 244 | 71 | 12 | HP:0001770 |
| HumanPheno | Intellectual disability, moderate | 1.15e-04 | 172 | 71 | 10 | HP:0002342 | |
| HumanPheno | Abnormality of calvarial morphology | DMXL2 SETD1B TRIO USP9X SMC1A KAT6A ACTB CPLX1 NSD1 APC MPDZ RFX7 ADNP HNRNPC HNRNPU BGN NEK1 NEU1 GET4 CLCN3 BRCA1 RTL1 RLIM SCN8A LRP2 PRKD1 FGFR2 TAF1 CAMTA1 CUX1 | 1.18e-04 | 1134 | 71 | 30 | HP:0002648 |
| HumanPheno | Short nose | TRIO SMC1A ACTB APC ZMYM2 RFX7 ADNP ZNF462 TRMT10A CDCA7 LRP2 SMARCE1 PLCB3 FGFR2 | 1.21e-04 | 325 | 71 | 14 | HP:0003196 |
| HumanPheno | Abnormal calvaria morphology | TPO DMXL2 SETD1B TRIO USP9X SMC1A KAT6A ACTB CPLX1 NSD1 APC MPDZ RFX7 ADNP HNRNPC HNRNPU BGN ZNF462 NEK1 NEU1 GET4 CLCN3 BRCA1 RTL1 RLIM SCN8A LRP2 PRKD1 FGFR2 TAF1 CAMTA1 CUX1 | 1.23e-04 | 1254 | 71 | 32 | HP:0002683 |
| HumanPheno | Abnormal midface morphology | TSR2 SETD1B TRIO SMC1A KAT6A ACTB CPLX1 APC RFX7 ADNP HNRNPU BGN ZNF462 NEK1 TRMT10A SALL1 CLCN3 RTL1 RLIM CTDP1 LRP2 FGFR2 | 1.39e-04 | 704 | 71 | 22 | HP:0000309 |
| HumanPheno | Generalized non-motor (absence) seizure | DMXL2 SETD1B NSD1 CHD2 RFX7 ADNP HNRNPC HNRNPU TRMT10A SCN8A | 1.39e-04 | 176 | 71 | 10 | HP:0002121 |
| HumanPheno | Abnormal nasal bridge morphology | TPO TSR2 DMXL2 TRIO USP9X SMC1A KAT6A ACTB CPLX1 NSD1 ZMYM2 CHD2 RFX7 ADNP NEK1 NEU1 BRCA1 CDCA7 RTL1 ZNF335 RLIM LRP2 NHS SMARCE1 PLCB3 PRKD1 FGFR2 TAF1 | 1.41e-04 | 1029 | 71 | 28 | HP:0000422 |
| HumanPheno | Ventricular septal defect | TSR2 DMXL2 TRIO CALM3 SMC1A KAT6A CPLX1 NSD1 ZMYM2 RFX7 ZNF462 NEK1 SALL1 RTL1 LRP2 SMARCE1 FGFR2 CUX1 | 1.50e-04 | 510 | 71 | 18 | HP:0001629 |
| HumanPheno | Abnormality of the abdominal wall | TPO DMXL2 USP9X KAT6A ACTB NSD1 APC RFX7 ADNP BGN UBA1 NEU1 SALL1 BRCA1 CDCA7 RTL1 LRP2 HEY2 FGFR2 | 1.58e-04 | 560 | 71 | 19 | HP:0004298 |
| HumanPheno | Hypospadias | TSR2 USP9X SMC1A CPLX1 NSD1 ZMYM2 REST UBA1 SALL1 BRCA1 CDCA7 RLIM SMARCE1 FGFR2 CUX1 | 1.63e-04 | 377 | 71 | 15 | HP:0000047 |
| HumanPheno | Abnormal cerebral ventricle morphology | USP9X SMC1A ACTB CPLX1 NSD1 APC MPDZ MCM7 ADNP HNRNPU BGN ZNF462 NEK1 NEU1 GET4 SALL1 CLCN3 BRCA1 CDCA7 ZNF335 CTDP1 SMARCE1 FGFR2 TAF1 ATM DNAAF1 DNAH5 CUX1 | 1.89e-04 | 1046 | 71 | 28 | HP:0002118 |
| HumanPheno | 2:1 atrioventricular block | 1.92e-04 | 2 | 71 | 2 | HP:0034305 | |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | TSR2 DMXL2 PRRX1 TRIO USP9X SMC1A KAT6A ACTB CPLX1 NSD1 APC ZMYM2 ADNP HNRNPU BGN NEK1 TRMT10A UBA1 SALL1 CLCN3 BRCA1 CDCA7 RTL1 ZNF335 RLIM CTDP1 LRP2 NHS SMARCE1 PLCB3 FGFR2 TAF1 CAMTA1 | 1.92e-04 | 1343 | 71 | 33 | HP:0009115 |
| HumanPheno | Facial asymmetry | 1.95e-04 | 149 | 71 | 9 | HP:0000324 | |
| HumanPheno | Abnormal ventricular septum morphology | TSR2 DMXL2 TRIO CALM3 SMC1A KAT6A CPLX1 NSD1 ZMYM2 RFX7 ZNF462 NEK1 SALL1 RTL1 LRP2 SMARCE1 FGFR2 CUX1 | 1.96e-04 | 521 | 71 | 18 | HP:0010438 |
| HumanPheno | Brachydactyly | TSR2 DMXL2 TRIO USP9X SMC1A KAT6A CPLX1 NSD1 APC ZMYM2 ADNP BGN NEK1 SALL1 RTL1 RLIM NHS SMARCE1 PLCB3 PRKD1 FGFR2 | 2.01e-04 | 670 | 71 | 21 | HP:0001156 |
| HumanPheno | Long philtrum | TRIO USP9X SMC1A ACTB CPLX1 NSD1 APC CHD2 RFX7 ADNP TRMT10A CLCN3 RTL1 FGFR2 TAF1 CAMTA1 | 2.02e-04 | 429 | 71 | 16 | HP:0000343 |
| HumanPheno | Myoclonic seizure | DMXL2 SETD1B SMC1A CPLX1 NSD1 ARFGEF1 CHD2 RFX7 NEU1 CLCN3 SCN8A CAMTA1 | 2.24e-04 | 262 | 71 | 12 | HP:0032794 |
| HumanPheno | Broad thumb | 2.26e-04 | 90 | 71 | 7 | HP:0011304 | |
| HumanPheno | Abnormal toe morphology | DMXL2 TRIO USP9X SMC1A KAT6A ACTB CPLX1 NSD1 APC ZMYM2 RFX7 ADNP BGN NEK1 TRMT10A UBA1 SALL1 BRCA1 RTL1 CTDP1 HEY2 SMARCE1 PRKD1 FGFR2 CAMTA1 | 2.48e-04 | 893 | 71 | 25 | HP:0001780 |
| HumanPheno | Abnormality of cartilage morphology | 2.51e-04 | 23 | 71 | 4 | HP:0410007 | |
| HumanPheno | Long fingers | SETD1B TRIO USP9X SMC1A CPLX1 ZMYM2 RFX7 ADNP BGN CLCN3 HEY2 SMARCE1 FGFR2 | 2.52e-04 | 306 | 71 | 13 | HP:0100807 |
| HumanPheno | Bilateral tonic-clonic seizure | DMXL2 SETD1B SMC1A CPLX1 NSD1 ARFGEF1 CHD2 RFX7 HNRNPC HNRNPU NEK1 GET4 CLCN3 SCN8A CAMTA1 | 2.65e-04 | 394 | 71 | 15 | HP:0002069 |
| HumanPheno | Ventriculomegaly | USP9X SMC1A ACTB CPLX1 NSD1 MPDZ MCM7 ADNP HNRNPU BGN ZNF462 NEK1 GET4 CLCN3 BRCA1 ZNF335 CTDP1 SMARCE1 FGFR2 TAF1 DNAAF1 DNAH5 CUX1 | 2.74e-04 | 790 | 71 | 23 | HP:0002119 |
| HumanPheno | Abnormal finger phalanx morphology | TSR2 DMXL2 TRIO USP9X SMC1A KAT6A ACTB CPLX1 NSD1 ADNP BGN NEK1 UBA1 SALL1 BRCA1 RTL1 RLIM CTDP1 NHS SMARCE1 PRKD1 FGFR2 | 2.80e-04 | 738 | 71 | 22 | HP:0005918 |
| HumanPheno | Displacement of the urethral meatus | TSR2 USP9X SMC1A CPLX1 NSD1 ZMYM2 REST UBA1 SALL1 BRCA1 CDCA7 RLIM SMARCE1 FGFR2 CUX1 | 2.88e-04 | 397 | 71 | 15 | HP:0100627 |
| HumanPheno | Intestinal malrotation | 2.89e-04 | 157 | 71 | 9 | HP:0002566 | |
| HumanPheno | Hypoplasia of the epiglottis | 2.90e-04 | 10 | 71 | 3 | HP:0005349 | |
| HumanPheno | Polymorphic ventricular tachycardia | 2.90e-04 | 10 | 71 | 3 | HP:0031677 | |
| HumanPheno | Abnormal male urethral meatus morphology | TSR2 USP9X SMC1A CPLX1 NSD1 ZMYM2 REST UBA1 SALL1 BRCA1 CDCA7 RLIM SMARCE1 FGFR2 CUX1 | 3.05e-04 | 399 | 71 | 15 | HP:0032076 |
| HumanPheno | Generalized-onset seizure | DMXL2 SETD1B SMC1A CPLX1 NSD1 ARFGEF1 CHD2 RFX7 ADNP HNRNPC HNRNPU NEK1 TRMT10A NEU1 GET4 CLCN3 SCN8A CAMTA1 | 3.38e-04 | 544 | 71 | 18 | HP:0002197 |
| HumanPheno | Non-motor seizure | DMXL2 SETD1B NSD1 CHD2 RFX7 ADNP HNRNPC HNRNPU TRMT10A SCN8A | 3.50e-04 | 197 | 71 | 10 | HP:0033259 |
| HumanPheno | Thick vermilion border | SETD1B TRIO USP9X APC ZMYM2 CHD2 ADNP NEU1 BRCA1 RTL1 SMARCE1 CAMTA1 | 4.02e-04 | 279 | 71 | 12 | HP:0012471 |
| HumanPheno | Bulbous nose | 4.12e-04 | 201 | 71 | 10 | HP:0000414 | |
| HumanPheno | Aplasia of the toes | 5.20e-04 | 74 | 71 | 6 | HP:0011306 | |
| HumanPheno | Absent toe | 5.20e-04 | 74 | 71 | 6 | HP:0010760 | |
| HumanPheno | Abnormal morphology of the limbic system | 5.40e-04 | 49 | 71 | 5 | HP:0007343 | |
| HumanPheno | Unilateral breast hypoplasia | 5.70e-04 | 3 | 71 | 2 | HP:0012813 | |
| HumanPheno | T-wave alternans | 5.70e-04 | 3 | 71 | 2 | HP:0012266 | |
| HumanPheno | 1-2 toe syndactyly | 5.70e-04 | 3 | 71 | 2 | HP:0010711 | |
| HumanPheno | Posteriorly rotated ears | PRRX1 USP9X SMC1A KAT6A ACTB CPLX1 NSD1 ZMYM2 MPDZ RFX7 ADNP CLCN3 RTL1 LRP2 FGFR2 CAMTA1 | 5.71e-04 | 470 | 71 | 16 | HP:0000358 |
| HumanPheno | Hypertelorism | TSR2 TRIO ACTB CPLX1 NSD1 APC ZMYM2 ADNP HNRNPC HNRNPU BGN ZNF462 NEK1 CLCN3 BRCA1 CDCA7 RLIM LRP2 HEY2 PLCB3 FGFR2 TAF1 CAMTA1 | 5.71e-04 | 830 | 71 | 23 | HP:0000316 |
| HumanPheno | Cutaneous syndactyly of toes | 5.94e-04 | 50 | 71 | 5 | HP:0010621 | |
| HumanPheno | High anterior hairline | 6.00e-04 | 76 | 71 | 6 | HP:0009890 | |
| Domain | Actin_CS | 1.33e-05 | 16 | 178 | 4 | IPR004001 | |
| Domain | ACTINS_2 | 1.72e-05 | 17 | 178 | 4 | PS00432 | |
| Domain | Peptidase_aspartic_dom | 1.72e-05 | 17 | 178 | 4 | IPR021109 | |
| Domain | Actin/actin-like_CS | 2.20e-05 | 18 | 178 | 4 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 2.76e-05 | 19 | 178 | 4 | PS01132 | |
| Domain | Aspartic_peptidase_N | 2.90e-05 | 7 | 178 | 3 | IPR012848 | |
| Domain | A1_Propeptide | 2.90e-05 | 7 | 178 | 3 | PF07966 | |
| Domain | TFIID_sub1_DUF3591 | 9.03e-05 | 2 | 178 | 2 | IPR022591 | |
| Domain | TBP-binding | 9.03e-05 | 2 | 178 | 2 | PF09247 | |
| Domain | DUF3591 | 9.03e-05 | 2 | 178 | 2 | PF12157 | |
| Domain | TAF_II_230-bd | 9.03e-05 | 2 | 178 | 2 | IPR009067 | |
| Domain | - | 9.03e-05 | 2 | 178 | 2 | 1.10.1100.10 | |
| Domain | TAF1_animal | 9.03e-05 | 2 | 178 | 2 | IPR011177 | |
| Domain | Aspartic_peptidase_A1 | 9.72e-05 | 10 | 178 | 3 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 9.72e-05 | 10 | 178 | 3 | IPR033121 | |
| Domain | Asp | 9.72e-05 | 10 | 178 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 9.72e-05 | 10 | 178 | 3 | PS51767 | |
| Domain | TPR_8 | 1.47e-04 | 53 | 178 | 5 | PF13181 | |
| Domain | - | 1.76e-04 | 12 | 178 | 3 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 1.76e-04 | 12 | 178 | 3 | PS00141 | |
| Domain | Actin | 2.05e-04 | 31 | 178 | 4 | IPR004000 | |
| Domain | Actin | 2.05e-04 | 31 | 178 | 4 | PF00022 | |
| Domain | ACTIN | 2.05e-04 | 31 | 178 | 4 | SM00268 | |
| Domain | Aspartic_peptidase_AS | 2.27e-04 | 13 | 178 | 3 | IPR001969 | |
| Domain | ATPase_dyneun-rel_AAA | 2.87e-04 | 14 | 178 | 3 | IPR011704 | |
| Domain | AAA_5 | 2.87e-04 | 14 | 178 | 3 | PF07728 | |
| Domain | Synaphin | 5.35e-04 | 4 | 178 | 2 | PF05835 | |
| Domain | Synaphin | 5.35e-04 | 4 | 178 | 2 | IPR008849 | |
| Domain | TPR_2 | 1.30e-03 | 50 | 178 | 4 | PF07719 | |
| Domain | TPR_2 | 1.30e-03 | 50 | 178 | 4 | IPR013105 | |
| Domain | Myb-like_dom | 1.32e-03 | 6 | 178 | 2 | IPR017877 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 2.71e-07 | 28 | 140 | 6 | MM14711 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 3.53e-06 | 65 | 140 | 7 | M39682 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 6.22e-06 | 13 | 140 | 4 | MM15078 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 7.50e-06 | 48 | 140 | 6 | MM14589 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 9.45e-06 | 5 | 140 | 3 | MM14493 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 1.01e-05 | 76 | 140 | 7 | M9052 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 1.88e-05 | 6 | 140 | 3 | MM14494 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 1.88e-05 | 6 | 140 | 3 | MM15662 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 3.22e-05 | 19 | 140 | 4 | M47543 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 3.26e-05 | 7 | 140 | 3 | MM1357 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 4.89e-05 | 21 | 140 | 4 | M47542 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 7.71e-05 | 9 | 140 | 3 | M3412 | |
| Pathway | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | 1.09e-04 | 10 | 140 | 3 | MM14570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 1.09e-04 | 10 | 140 | 3 | M47954 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.18e-04 | 26 | 140 | 4 | M27053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.37e-04 | 27 | 140 | 4 | MM15053 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 1.49e-04 | 11 | 140 | 3 | MM14810 | |
| Pathway | WP_GASTRIC_ACID_PRODUCTION | 1.49e-04 | 11 | 140 | 3 | M39726 | |
| Pathway | WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 1.49e-04 | 11 | 140 | 3 | M42562 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.49e-04 | 11 | 140 | 3 | M47958 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.59e-04 | 28 | 140 | 4 | M47508 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.82e-04 | 29 | 140 | 4 | MM15219 | |
| Pathway | REACTOME_ENOS_ACTIVATION | 1.98e-04 | 12 | 140 | 3 | MM14817 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 1.98e-04 | 12 | 140 | 3 | MM15142 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 1.98e-04 | 12 | 140 | 3 | M47956 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 2.09e-04 | 30 | 140 | 4 | M27566 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.70e-04 | 32 | 140 | 4 | MM15143 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 3.22e-04 | 14 | 140 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 3.22e-04 | 14 | 140 | 3 | M47388 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 3.22e-04 | 14 | 140 | 3 | MM15052 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 3.22e-04 | 14 | 140 | 3 | MM1473 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 3.22e-04 | 14 | 140 | 3 | MM15391 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.57e-04 | 175 | 140 | 8 | MM14941 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 4.00e-04 | 15 | 140 | 3 | M47385 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 4.00e-04 | 15 | 140 | 3 | M15181 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 4.00e-04 | 15 | 140 | 3 | MM15103 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 4.00e-04 | 15 | 140 | 3 | MM1387 | |
| Pathway | REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION | 4.00e-04 | 15 | 140 | 3 | MM14795 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 4.88e-04 | 16 | 140 | 3 | MM14492 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 4.88e-04 | 16 | 140 | 3 | MM1483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 4.88e-04 | 16 | 140 | 3 | M47449 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 5.04e-04 | 101 | 140 | 6 | M1979 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 5.85e-04 | 39 | 140 | 4 | MM14496 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 5.89e-04 | 17 | 140 | 3 | M10066 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 5.89e-04 | 17 | 140 | 3 | M2482 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 5.89e-04 | 17 | 140 | 3 | M47387 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 5.89e-04 | 17 | 140 | 3 | M47560 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 5.89e-04 | 17 | 140 | 3 | M5940 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 5.89e-04 | 17 | 140 | 3 | MM1372 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 5.89e-04 | 17 | 140 | 3 | M2349 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 6.48e-04 | 70 | 140 | 5 | M3115 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 7.01e-04 | 18 | 140 | 3 | M47580 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 7.01e-04 | 18 | 140 | 3 | M5290 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 7.01e-04 | 18 | 140 | 3 | MM15577 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 7.01e-04 | 18 | 140 | 3 | MM1385 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 7.01e-04 | 18 | 140 | 3 | M3430 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 7.55e-04 | 109 | 140 | 6 | MM15074 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 8.27e-04 | 19 | 140 | 3 | MM1453 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 8.27e-04 | 19 | 140 | 3 | M47957 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 8.66e-04 | 154 | 140 | 7 | MM15974 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 9.12e-04 | 113 | 140 | 6 | M16817 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 9.30e-04 | 44 | 140 | 4 | M39845 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 9.34e-04 | 156 | 140 | 7 | M39475 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 9.66e-04 | 20 | 140 | 3 | MM1445 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.01e-03 | 45 | 140 | 4 | MM15040 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 1.10e-03 | 46 | 140 | 4 | MM14933 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.12e-03 | 21 | 140 | 3 | M11650 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.29e-03 | 22 | 140 | 3 | MM15104 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 1.29e-03 | 22 | 140 | 3 | MM15519 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 1.29e-03 | 48 | 140 | 4 | M26964 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 1.40e-03 | 49 | 140 | 4 | MM1442 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.47e-03 | 23 | 140 | 3 | M47512 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.47e-03 | 23 | 140 | 3 | MM15222 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.58e-03 | 272 | 140 | 9 | M29619 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 1.62e-03 | 51 | 140 | 4 | M2288 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.67e-03 | 24 | 140 | 3 | M47509 | |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 1.88e-03 | 25 | 140 | 3 | MM15574 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 1.88e-03 | 25 | 140 | 3 | M1547 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 1.88e-03 | 25 | 140 | 3 | MM1441 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.88e-03 | 25 | 140 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.88e-03 | 25 | 140 | 3 | M47511 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.01e-03 | 54 | 140 | 4 | MM15202 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 2.01e-03 | 90 | 140 | 5 | MM15882 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 2.11e-03 | 26 | 140 | 3 | MM1346 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 2.11e-03 | 26 | 140 | 3 | M17941 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 2.11e-03 | 26 | 140 | 3 | MM14495 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 2.11e-03 | 26 | 140 | 3 | MM1371 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 2.11e-03 | 26 | 140 | 3 | MM1431 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 2.35e-03 | 27 | 140 | 3 | M14899 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 2.35e-03 | 27 | 140 | 3 | M7739 | |
| Pathway | BIOCARTA_NO1_PATHWAY | 2.62e-03 | 28 | 140 | 3 | M4383 | |
| Pathway | WP_DRAVET_SYNDROME | 2.62e-03 | 28 | 140 | 3 | M45519 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 2.90e-03 | 29 | 140 | 3 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 2.90e-03 | 29 | 140 | 3 | M13494 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 2.90e-03 | 29 | 140 | 3 | MM1495 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 3.12e-03 | 301 | 140 | 9 | MM15983 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 3.20e-03 | 30 | 140 | 3 | M9664 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 3.20e-03 | 30 | 140 | 3 | MM15170 | |
| Pubmed | USP34 CASP8AP2 NOL4 ZNF536 TTC28 APC ZMYM2 MCM7 INPP5F ADNP ZNF462 NEK1 SALL1 ZFHX4 ATF7IP LRP2 TNKS1BP1 TAF1 CUX1 PROX1 | 1.16e-13 | 418 | 184 | 20 | 34709266 | |
| Pubmed | NOL4 ZNF536 ZNF143 AKAP8 CALM1 CALM2 USP9X SMC1A ZMYM2 GON4L RFX7 ADNP ASH2L PWP1 ZNF462 SALL1 UBN1 BRCA1 ZFHX4 ATF7IP ZNF451 CD2BP2 DDX18 RLIM LRP2 SMARCE1 TAF1 CPSF2 TAF1L HSPA4 CUX1 PPP6R3 BRMS1 | 9.22e-13 | 1429 | 184 | 33 | 35140242 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CASP8AP2 AKAP8 CALM1 SMC1A ACTB NSD1 ZMYM2 NOL11 WWTR1 CHD2 REST RFX7 WDR76 ADNP TTF1 ASH2L HNRNPC HNRNPU MDN1 UBN1 BRCA1 CD2BP2 DDX18 ANAPC2 HTATSF1 SMARCE1 CPSF2 TAF1L CUX1 BRMS1 | 1.04e-11 | 1294 | 184 | 30 | 30804502 |
| Pubmed | MAGI1 DMXL2 AKAP8 CALM1 TRIO CALM2 USP28 USP9X CYTH2 ACTB NSD1 APC ZMYM2 MPDZ ADNP HNRNPU ZNF462 UBA1 MDN1 ATF7IP SIPA1L1 PRKD1 CPSF2 CUX1 RASAL1 PROX1 | 1.07e-11 | 963 | 184 | 26 | 28671696 | |
| Pubmed | CALM1 SYNM USP28 USP9X POTEF CYTH2 SMC1A ACTB MCM7 POTEKP HNRNPC HNRNPU MDN1 TNKS1BP1 FGFR2 DMD NEXN HSPA4 PPP6R3 | 9.29e-11 | 538 | 184 | 19 | 28524877 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | AKAP8 SMC1A ZMYM2 REST RFX7 HNRNPC PPP1R2 PWP1 TBC1D10B UBA1 MDN1 UBN1 SIPA1L1 ZNF335 CTDP1 TNKS1BP1 PLCB3 ATM SCFD1 CPSF2 FKBP5 PPP6R3 | 1.79e-10 | 774 | 184 | 22 | 15302935 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAGI1 JCAD ZBTB16 AKAP8 TTC28 TRIO POTEF APC MPDZ WWTR1 INPP5F RFX7 LYST RGS12 ITPKB NEK1 TBC1D10B MDN1 SIPA1L1 NHS TNKS1BP1 BOD1L1 SH3RF3 | 2.25e-10 | 861 | 184 | 23 | 36931259 |
| Pubmed | PRUNE2 USP34 CASP8AP2 DMXL2 TTC28 SMC1A ZNF462 CEP72 SIPA1L1 TNKS1BP1 GRIP2 CAMTA1 ARAP1 | 2.67e-10 | 225 | 184 | 13 | 12168954 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | CALM3 SMC1A ZMYM2 GON4L MCM7 CHD2 WDR76 ASH2L HNRNPC TBC1D10B UBA1 MDN1 DDX18 TAF1 CPSF2 CUX1 | 4.07e-10 | 394 | 184 | 16 | 27248496 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 CASP8AP2 SETD1B TTC28 USP28 USP9X APC ZMYM2 MCM7 POTEE SALL1 UBN1 ATF7IP ZNF451 CD2BP2 TNKS1BP1 POTEI FKBP5 PPP6R3 | 4.12e-10 | 588 | 184 | 19 | 38580884 |
| Pubmed | DSPP USP9X POTEF SMC1A ACTB CHD2 POTEKP REST PHAX HNRNPC HNRNPU PWP1 POTEE UBA1 GET4 CLCN3 CD2BP2 DDX18 HTATSF1 SMARCE1 FGFR2 SCFD1 POTEI HSPA4 FKBP5 NLRP5 | 5.19e-10 | 1153 | 184 | 26 | 29845934 | |
| Pubmed | A network of control mediated by regulator of calcium/calmodulin-dependent signaling. | 7.58e-10 | 4 | 184 | 4 | 15499021 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | DCAF1 USP9X ZMYM2 MCM7 INPP5F ASH2L GET4 RLIM BOD1L1 ATM PJA1 DMD CPSF2 PPP6R3 | 1.53e-09 | 313 | 184 | 14 | 38270169 |
| Pubmed | 3.78e-09 | 5 | 184 | 4 | 21436055 | ||
| Pubmed | DCAF1 USP34 ZNF536 USP9X ZMYM2 PWP1 ZNF462 MDN1 ZFHX4 ANAPC2 BOD1L1 SCFD1 CUX1 | 4.17e-09 | 282 | 184 | 13 | 23667531 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NOL4 SDE2 SMC1A KAT6A NSD1 ZMYM2 CHD2 PHAX WDR76 ADNP ZNF462 UBN1 BRCA1 ZNF451 SMARCE1 BOD1L1 TAF1 CUX1 | 4.77e-09 | 608 | 184 | 18 | 36089195 |
| Pubmed | USP34 JCAD DMXL2 CALM1 TTC28 TRIO SYNM USP28 USP9X SMC1A ZBTB43 ACTB APC ZMYM2 ZNF451 SIPA1L1 DDX18 NEMF LRP2 SMARCE1 TTC17 SPARCL1 TAF1 ATM PJA1 CUX1 | 4.95e-09 | 1285 | 184 | 26 | 35914814 | |
| Pubmed | USP34 CASP8AP2 SDE2 USP28 SMC1A NOL11 MCM7 CHD2 PHAX ADNP UBA1 MDN1 UBN1 ZNF451 CD2BP2 DDX18 HTATSF1 SMARCE1 BOD1L1 TAF1 ATM CPSF2 FKBP5 | 5.07e-09 | 1014 | 184 | 23 | 32416067 | |
| Pubmed | TTC28 USP9X NSD1 MPDZ MCM7 WWTR1 PHAX ADNP ASH2L NEK1 UBA1 SMARCE1 TNKS1BP1 BOD1L1 TAF1 CUX1 PPP6R3 | 6.75e-09 | 549 | 184 | 17 | 38280479 | |
| Pubmed | JCAD MYH2 ZNF536 ZNF143 TTC28 USP9X FBF1 ZMYM2 CHD2 ASH2L ITPKB SALL1 MDN1 CEP72 PHACTR3 SMARCE1 DNAAF1 CUX1 | 1.00e-08 | 638 | 184 | 18 | 31182584 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.13e-08 | 15 | 184 | 5 | 16824795 | |
| Pubmed | DMXL2 SETD1B CALM1 CALM2 CALM3 USP9X KAT6A NSD1 APC INPP5F MMP20 NEK1 UBA1 LRP2 PLCB3 TAF1 DNAH5 TAF1L PGA3 | 1.39e-08 | 730 | 184 | 19 | 34857952 | |
| Pubmed | PIK3AP1 USP34 ZNF536 AKAP8 CALM1 TTC28 TRIO UGGT1 SYTL2 APC MPDZ ITPR2 PPP1R2 ZNF451 TTC17 BOD1L1 CPSF2 FKBP5 SLC26A6 | 1.48e-08 | 733 | 184 | 19 | 34672954 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | ZNF143 AKAP8 USP9X SMC1A ZMYM2 ADNP ASH2L ZNF462 SALL1 SMARCE1 | 2.32e-08 | 167 | 184 | 10 | 20362541 |
| Pubmed | 2.62e-08 | 7 | 184 | 4 | 12821674 | ||
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | CALM1 CALM2 ACTB MCM7 HNRNPC HNRNPU ZNF462 UBA1 SALL1 UBN1 DDX18 HSPA4 CUX1 | 2.89e-08 | 332 | 184 | 13 | 30595499 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF143 SMC1A ACTB NSD1 ZMYM2 NOL11 ADNP HNRNPC HNRNPU SALL1 UBN1 BRCA1 ATF7IP ZNF451 DDX18 HTATSF1 SMARCE1 BOD1L1 TAF1 TAF1L CUX1 | 4.12e-08 | 954 | 184 | 21 | 36373674 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | MYH2 MYL1 CALM1 CALM2 CALM3 ACTB MCM7 HNRNPC HNRNPU ITPR2 GET4 SIPA1L1 DDX18 TNKS1BP1 HSPA4 CUX1 PROX1 | 4.56e-08 | 626 | 184 | 17 | 33644029 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | AKAP8 CALM1 CALM2 CALM3 USP9X TIMM23B SMC1A UGGT1 ACTB NOL11 TIMM23 MCM7 HNRNPC HNRNPU UBA1 NEU1 GET4 MDN1 CD2BP2 RLIM CPSF2 HSPA4 FKBP5 PPP6R3 | 6.04e-08 | 1257 | 184 | 24 | 37317656 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOL4 DMXL2 AKAP8 SMC1A ACTB APC ZMYM2 CHD2 ADNP HNRNPC HNRNPU PWP1 ZNF462 TBC1D10B CD2BP2 DDX18 NEMF SMARCE1 TNKS1BP1 ATM CPSF2 PROX1 | 7.67e-08 | 1082 | 184 | 22 | 38697112 |
| Pubmed | 9.36e-08 | 9 | 184 | 4 | 16364570 | ||
| Pubmed | MAGI1 JCAD TTC28 USP9X SMC1A FBF1 APC MPDZ INPP5F CEP72 SIPA1L1 SH3RF3 HSPA4 PPP6R3 | 1.29e-07 | 446 | 184 | 14 | 24255178 | |
| Pubmed | 1.39e-07 | 45 | 184 | 6 | 22926577 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 29932249 | ||
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 1.46e-07 | 3 | 184 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 1.46e-07 | 3 | 184 | 3 | 9923700 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 9681195 | ||
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 1.46e-07 | 3 | 184 | 3 | 23893133 | |
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 1.46e-07 | 3 | 184 | 3 | 8573130 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 10899953 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 7926498 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 9561228 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 21455714 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 19800305 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 8862395 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 1.46e-07 | 3 | 184 | 3 | 1968039 | |
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 1.46e-07 | 3 | 184 | 3 | 2566575 | |
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 1.46e-07 | 3 | 184 | 3 | 19890696 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 6774973 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 6300126 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 24004680 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 14978283 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 33191766 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 23034090 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 1.46e-07 | 3 | 184 | 3 | 3554488 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 23521833 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 3017318 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 9855083 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 2478370 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 19651602 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 1.46e-07 | 3 | 184 | 3 | 10675278 | |
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 1.46e-07 | 3 | 184 | 3 | 3839486 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 3467902 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 4586732 | ||
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 1.46e-07 | 3 | 184 | 3 | 2892778 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 24383519 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 1.46e-07 | 3 | 184 | 3 | 2831884 | |
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 1.46e-07 | 3 | 184 | 3 | 3384819 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 21799007 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 1812762 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 7923573 | ||
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 1.46e-07 | 3 | 184 | 3 | 18786401 | |
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 1.46e-07 | 3 | 184 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 1.46e-07 | 3 | 184 | 3 | 1956484 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 11072229 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 22992016 | ||
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 1.46e-07 | 3 | 184 | 3 | 8504820 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 20428942 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 15063758 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 9525001 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 7886402 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 1.46e-07 | 3 | 184 | 3 | 17582331 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 21547904 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 18370588 | ||
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 1.46e-07 | 3 | 184 | 3 | 9278050 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 15719022 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 1.46e-07 | 3 | 184 | 3 | 11847276 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 10416864 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 24170207 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 7828884 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 1.46e-07 | 3 | 184 | 3 | 3014868 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 1.46e-07 | 3 | 184 | 3 | 2799289 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 19872561 | ||
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 1.46e-07 | 3 | 184 | 3 | 2469574 | |
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 1.46e-07 | 3 | 184 | 3 | 15632291 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 8053437 | ||
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 1.46e-07 | 3 | 184 | 3 | 2229438 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 25314140 | ||
| Interaction | HDAC1 interactions | DCAF1 CASP8AP2 MYH2 ZNF536 ZBTB16 TTC28 SMC1A ZBTB43 ACTB APC ARFGEF1 ZMYM2 GON4L MCM7 REST INPP5F WDR76 ADNP ASH2L HNRNPC HNRNPU NEK1 SALL1 BRCA1 ZFHX4 HEY2 SMARCE1 TNKS1BP1 TAF1 ATM CPSF2 HSPA4 CUX1 MXD1 PPP6R3 BRMS1 | 2.28e-11 | 1108 | 184 | 36 | int:HDAC1 |
| Interaction | SIN3A interactions | ZBTB16 ZMYM2 GON4L WWTR1 REST ASH2L RLIM CTDP1 HEY2 SMARCE1 BOD1L1 TAF1 ATM CPSF2 HSPA4 MXD1 PPP6R3 BRMS1 | 1.36e-08 | 380 | 184 | 18 | int:SIN3A |
| Interaction | KDM1A interactions | CCDC14 USP34 CASP8AP2 NOL4 TTC28 USP28 USP9X APC ZMYM2 MCM7 INPP5F WDR76 ADNP HNRNPC ZNF462 NEK1 BRCA1 ZFHX4 ATF7IP ZNF451 LRP2 TNKS1BP1 TAF1 CPSF2 CUX1 PPP6R3 PROX1 | 1.28e-07 | 941 | 184 | 27 | int:KDM1A |
| Interaction | RCOR1 interactions | USP34 CASP8AP2 NOL4 ZNF536 TTC28 ACTB APC ZMYM2 REST HNRNPU NEK1 SALL1 ZFHX4 SMARCE1 TNKS1BP1 TAF1 HSPA4 CUX1 PPP6R3 | 1.43e-07 | 494 | 184 | 19 | int:RCOR1 |
| Interaction | AMOT interactions | CCDC14 MAGI1 JCAD CALM3 USP9X SMC1A ACTB APC MPDZ WWTR1 CEP72 SIPA1L1 RLIM CTDP1 KIAA1328 | 1.91e-07 | 312 | 184 | 15 | int:AMOT |
| Interaction | ARPP21 interactions | 4.58e-07 | 8 | 184 | 4 | int:ARPP21 | |
| Interaction | FOXJ2 interactions | 7.55e-07 | 81 | 184 | 8 | int:FOXJ2 | |
| Interaction | TERF2IP interactions | ZNF536 SDE2 ARPP21 USP28 NSD1 ZMYM2 NOL11 MCM7 ADNP HNRNPU PPP1R2 BRCA1 ATF7IP HTATSF1 BOD1L1 TAF1 HSPA4 CUX1 PPP6R3 | 7.75e-07 | 552 | 184 | 19 | int:TERF2IP |
| Interaction | CEP290 interactions | CCDC14 CALM1 CALM2 CALM3 USP9X MCM7 HNRNPU NEK1 UBA1 CEP72 KIAA1328 | 7.98e-07 | 179 | 184 | 11 | int:CEP290 |
| Interaction | NR3C1 interactions | JCAD CASP8AP2 MYH2 ZNF536 ZNF143 ZBTB16 CALM1 TTC28 USP9X SMC1A FBF1 ZMYM2 CHD2 ASH2L HNRNPU ITPKB PWP1 SALL1 MDN1 CEP72 PHACTR3 SMARCE1 DNAAF1 HSPA4 FKBP5 CUX1 | 8.87e-07 | 974 | 184 | 26 | int:NR3C1 |
| Interaction | H3-3A interactions | DCAF1 NOL4 SDE2 SETD1B SMC1A KAT6A NSD1 ZMYM2 CHD2 PHAX WDR76 ADNP HNRNPC UBN1 BRCA1 ZNF451 PHACTR3 SMARCE1 BOD1L1 TAF1 CUX1 PPP6R3 | 1.42e-06 | 749 | 184 | 22 | int:H3-3A |
| Interaction | SUMO2 interactions | CASP8AP2 CALM1 USP28 USP9X SMC1A ACTB ZMYM2 HNRNPU UBA1 SALL1 MDN1 BRCA1 ATF7IP ZNF451 ANAPC2 BOD1L1 TAF1 CPSF2 CUX1 | 2.13e-06 | 591 | 184 | 19 | int:SUMO2 |
| Interaction | RDX interactions | DCAF1 CALM1 ACTB WDR76 HNRNPC HNRNPU CRACD UBA1 GET4 BRCA1 TNKS1BP1 NEXN HSPA4 | 2.22e-06 | 284 | 184 | 13 | int:RDX |
| Interaction | LATS1 interactions | DCAF1 MAGI1 JCAD MYH2 MYL1 USP9X APC MPDZ WWTR1 CHD2 REST MDN1 SIPA1L1 CPSF2 FKBP5 PPP6R3 | 3.00e-06 | 440 | 184 | 16 | int:LATS1 |
| Interaction | PHF21A interactions | USP34 CASP8AP2 NOL4 ZNF536 TTC28 APC ZMYM2 MCM7 INPP5F NEK1 SALL1 ZFHX4 TNKS1BP1 TAF1 | 3.42e-06 | 343 | 184 | 14 | int:PHF21A |
| Interaction | NUP43 interactions | DCAF1 USP34 CASP8AP2 SETD1B SMC1A NSD1 APC ZMYM2 NOL11 GON4L TTF1 ZNF462 BRCA1 ATF7IP CD2BP2 DDX18 RLIM SMARCE1 BOD1L1 | 4.78e-06 | 625 | 184 | 19 | int:NUP43 |
| Interaction | YAP1 interactions | JCAD CALM1 CALM3 USP9X POTEF ACTB NSD1 MPDZ MCM7 WWTR1 POTEKP PHAX ADNP ASH2L HNRNPC HNRNPU POTEE UBA1 SMARCE1 TNKS1BP1 BOD1L1 PRKD1 TAF1 POTEI HSPA4 CUX1 | 7.48e-06 | 1095 | 184 | 26 | int:YAP1 |
| Interaction | TP53BP1 interactions | USP34 USP28 SMC1A UGGT1 WWTR1 ASH2L NEK1 TBC1D10B MDN1 BRCA1 ZNF451 CD2BP2 ANAPC2 SMARCE1 ATM CUX1 ARAP1 | 8.33e-06 | 533 | 184 | 17 | int:TP53BP1 |
| Interaction | USP7 interactions | ZNF536 USP28 USP9X FBF1 NSD1 APC GON4L WWTR1 FAM170A WDR76 IFIT2 HNRNPC PPP1R2 PWP1 PTPN5 SALL1 MDN1 UBN1 BRCA1 ZNF335 CTDP1 ZNF264 SPARCL1 TAF1 PJA1 DMD DNAH5 FKBP5 PPP6R3 | 8.48e-06 | 1313 | 184 | 29 | int:USP7 |
| Interaction | YWHAE interactions | DCAF1 JCAD AKAP8 CALM1 TTC28 POTEF CYTH2 ACTB APC WWTR1 INPP5F MMP20 LYST HNRNPC RGS12 HNRNPU PPP1R2 CRACD NEK1 UBA1 BRCA1 SIPA1L1 NHS TTC17 PRKD1 SH3RF3 HSPA4 BRMS1 | 1.04e-05 | 1256 | 184 | 28 | int:YWHAE |
| Interaction | RBBP5 interactions | SETD1B WDR76 ASH2L BRCA1 ZNF335 DDX18 SMARCE1 BOD1L1 TAF1 CPSF2 HSPA4 PPP6R3 | 1.37e-05 | 287 | 184 | 12 | int:RBBP5 |
| Interaction | HDAC2 interactions | DCAF1 ZBTB16 TRIO SMC1A ACTB ZMYM2 MCM7 REST ASH2L HNRNPC HNRNPU SALL1 BRCA1 RLIM SMARCE1 TNKS1BP1 DMD CPSF2 HSPA4 MXD1 PPP6R3 BRMS1 | 1.41e-05 | 865 | 184 | 22 | int:HDAC2 |
| Interaction | TFE3 interactions | CALM1 ACTB MCM7 HNRNPC HNRNPU ZNF462 UBA1 SALL1 UBN1 DDX18 SMARCE1 HSPA4 CUX1 | 1.75e-05 | 344 | 184 | 13 | int:TFE3 |
| Interaction | HAUS2 interactions | 2.08e-05 | 126 | 184 | 8 | int:HAUS2 | |
| Interaction | SP7 interactions | ZNF536 AKAP8 SMC1A ASH2L PWP1 BRCA1 ZFHX4 CD2BP2 SMARCE1 CPSF2 CUX1 PPP6R3 | 2.42e-05 | 304 | 184 | 12 | int:SP7 |
| Interaction | YWHAH interactions | MAGI1 JCAD AKAP8 TTC28 TRIO POTEF CYTH2 APC MPDZ WWTR1 INPP5F RFX7 LYST RGS12 NEK1 TBC1D10B UBA1 CDCA7 SIPA1L1 NHS TNKS1BP1 BOD1L1 PRKD1 SH3RF3 HSPA4 | 2.45e-05 | 1102 | 184 | 25 | int:YWHAH |
| Interaction | SPATA17 interactions | 2.55e-05 | 7 | 184 | 3 | int:SPATA17 | |
| Interaction | TXNIP interactions | 2.62e-05 | 212 | 184 | 10 | int:TXNIP | |
| Interaction | POC5 interactions | 2.65e-05 | 95 | 184 | 7 | int:POC5 | |
| Interaction | DDA1 interactions | DCAF1 SETD1B KAT6A GON4L PHAX ADNP TTF1 HNRNPC PWP1 UTP25 CD2BP2 TAF1 CPSF2 | 3.53e-05 | 368 | 184 | 13 | int:DDA1 |
| Interaction | TEAD1 interactions | 3.56e-05 | 176 | 184 | 9 | int:TEAD1 | |
| Interaction | ATRX interactions | CALM1 CALM3 SMC1A KAT6A NSD1 ZMYM2 MCM7 ADNP NEK1 SALL1 ZFHX4 | 3.60e-05 | 267 | 184 | 11 | int:ATRX |
| Interaction | SOX2 interactions | DCAF1 USP34 ZNF536 AKAP8 NRDC USP9X SMC1A NSD1 ZMYM2 NOL11 PHAX ADNP ASH2L HNRNPC HNRNPU ITPR2 PWP1 ZNF462 UBA1 SALL1 MDN1 ZFHX4 SIPA1L1 DDX18 ANAPC2 SMARCE1 BOD1L1 SCFD1 CUX1 | 3.73e-05 | 1422 | 184 | 29 | int:SOX2 |
| Interaction | AR interactions | USP34 ZBTB16 CALM1 USP28 SMC1A ACTB NSD1 ZMYM2 MCM7 ADNP ASH2L HNRNPU ZNF462 MDN1 BRCA1 ZNF451 SMARCE1 PRKD1 TAF1 HSPA4 FKBP5 CUX1 BRMS1 | 3.82e-05 | 992 | 184 | 23 | int:AR |
| Interaction | KCNN1 interactions | 4.05e-05 | 8 | 184 | 3 | int:KCNN1 | |
| Interaction | USP15 interactions | MYH2 USP28 SMC1A KAT6A ACTB APC ZMYM2 MCM7 WWTR1 ASH2L HNRNPC HNRNPU PPP1R2 PRKD1 FKBP5 PPP6R3 | 4.32e-05 | 546 | 184 | 16 | int:USP15 |
| Interaction | PML interactions | USP34 CASP8AP2 SDE2 ZBTB16 CALM1 CALM2 CALM3 UGGT1 KAT6A ZMYM2 TIMM23 HNRNPU ITPR2 PPP1R2 MDN1 UBN1 BRCA1 ATF7IP ZNF451 TNKS1BP1 ATM MXD1 | 4.44e-05 | 933 | 184 | 22 | int:PML |
| Interaction | HNF4A interactions | ZMYM2 ADNP ASH2L ZNF462 UBN1 ATF7IP ZNF451 SMARCE1 DMD CUX1 PROX1 | 4.71e-05 | 275 | 184 | 11 | int:HNF4A |
| Interaction | CHD4 interactions | NOL4 AKAP8 SMC1A KAT6A ACTB ZMYM2 WDR76 ADNP HNRNPC HNRNPU ZNF462 SALL1 MDN1 ZFHX4 CD2BP2 DDX18 HTATSF1 SMARCE1 ATM CPSF2 PPP6R3 PROX1 | 4.81e-05 | 938 | 184 | 22 | int:CHD4 |
| Interaction | CSNK1A1 interactions | USP34 NOL4 KAT6A ACTB APC FAM170A HNRNPC HTATSF1 PRKD1 ATM CPSF2 HSPA4 FKBP5 | 5.04e-05 | 381 | 184 | 13 | int:CSNK1A1 |
| Interaction | HDAC4 interactions | MAGI1 ZBTB16 SETD1B CALM1 TRIO USP9X APC MPDZ REST HNRNPU TBC1D10B SIPA1L1 NEMF SCN8A PLCB3 ATM SH3RF3 INPP5J BRMS1 | 5.34e-05 | 744 | 184 | 19 | int:HDAC4 |
| Interaction | ERRFI1 interactions | 5.70e-05 | 107 | 184 | 7 | int:ERRFI1 | |
| Interaction | YWHAZ interactions | JCAD DMXL2 AKAP8 CALM1 TTC28 CALM3 POTEF SMC1A KAT6A APC NOL11 WWTR1 POTEKP INPP5F WDR76 LYST RGS12 CRACD NEK1 UBA1 BRCA1 CDCA7 SIPA1L1 NHS PRKD1 ATM HSPA4 | 6.71e-05 | 1319 | 184 | 27 | int:YWHAZ |
| Interaction | CHD3 interactions | AKAP8 SMC1A KAT6A ACTB ZMYM2 MCM7 ADNP HNRNPC HNRNPU SALL1 MDN1 ZFHX4 CD2BP2 DDX18 HTATSF1 SMARCE1 TAF1 CPSF2 CUX1 | 6.72e-05 | 757 | 184 | 19 | int:CHD3 |
| Interaction | RBBP7 interactions | TTC28 SMC1A ZMYM2 WWTR1 REST WDR76 ASH2L ZNF462 SALL1 UBN1 BRCA1 CPSF2 HSPA4 PPP6R3 BRMS1 | 6.77e-05 | 507 | 184 | 15 | int:RBBP7 |
| Interaction | WDR5 interactions | CLUAP1 SETD1B KAT6A ACTB ZMYM2 NOL11 PHAX ADNP ASH2L HNRNPC HNRNPU PWP1 ZNF462 POTEE BRCA1 CEP72 ZNF335 DDX18 ANAPC2 BOD1L1 TAF1 CPSF2 HSPA4 PPP6R3 | 6.78e-05 | 1101 | 184 | 24 | int:WDR5 |
| Interaction | ACTC1 interactions | CALM1 POTEF ACTB PHAX ADNP ASH2L POTEE CRACD UBA1 PHACTR3 RLIM HTATSF1 SMARCE1 TTC17 BOD1L1 DMD POTEI NEXN | 6.96e-05 | 694 | 184 | 18 | int:ACTC1 |
| Interaction | YWHAG interactions | MAGI1 JCAD AKAP8 TTC28 POTEF APC MPDZ WWTR1 INPP5F RFX7 LYST RGS12 ITPKB CRACD NEK1 TBC1D10B UBA1 MDN1 CDCA7 SIPA1L1 NHS BOD1L1 PRKD1 SH3RF3 HSPA4 PPP6R3 | 6.97e-05 | 1248 | 184 | 26 | int:YWHAG |
| Interaction | CHD8 interactions | 7.28e-05 | 193 | 184 | 9 | int:CHD8 | |
| Interaction | LATS2 interactions | DCAF1 MAGI1 JCAD USP9X APC MPDZ WWTR1 CEP72 SIPA1L1 ANAPC2 FKBP5 | 7.36e-05 | 289 | 184 | 11 | int:LATS2 |
| Interaction | RBBP4 interactions | SMC1A ACTB ZMYM2 MCM7 WDR76 ASH2L HNRNPC ZNF462 SALL1 BRCA1 SMARCE1 CPSF2 HSPA4 CUX1 PROX1 BRMS1 | 7.63e-05 | 573 | 184 | 16 | int:RBBP4 |
| Interaction | IQCG interactions | 8.57e-05 | 10 | 184 | 3 | int:IQCG | |
| Interaction | TERF1 interactions | ZBTB16 ARPP21 USP9X KAT6A MCM7 PTPN5 SALL1 BRCA1 RLIM ATM DMD HSPA4 | 8.67e-05 | 347 | 184 | 12 | int:TERF1 |
| Interaction | POU5F1 interactions | DCAF1 USP34 ZNF143 AKAP8 USP9X SMC1A ZBTB43 ZMYM2 ASH2L HNRNPU ZNF462 SALL1 SMARCE1 TAF1 PLD2 CPSF2 | 9.52e-05 | 584 | 184 | 16 | int:POU5F1 |
| Interaction | KPNA1 interactions | USP9X PHAX ADNP ASH2L HNRNPC HNRNPU ZFHX4 CD2BP2 SMARCE1 BOD1L1 ATM HSPA4 | 9.67e-05 | 351 | 184 | 12 | int:KPNA1 |
| Interaction | GSK3A interactions | TTC28 TRIO APC MPDZ RFX7 HNRNPU PPP1R2 PPP1R2B NEK1 MDN1 SIPA1L1 NHS TNKS1BP1 PPP6R3 | 9.68e-05 | 464 | 184 | 14 | int:GSK3A |
| Interaction | SENP3 interactions | DCAF1 POTEF KAT6A MCM7 ASH2L MDN1 ATF7IP ZNF451 RLIM TAF1 PPP6R3 | 1.06e-04 | 301 | 184 | 11 | int:SENP3 |
| Interaction | AGO4 interactions | 1.06e-04 | 118 | 184 | 7 | int:AGO4 | |
| Interaction | MAD2L1 interactions | TSR2 KAT6A APC NOL11 ADNP TRMT10A ATF7IP ANAPC2 CTDP1 BOD1L1 | 1.12e-04 | 252 | 184 | 10 | int:MAD2L1 |
| Interaction | POLR2A interactions | SETD1B SMC1A ACTB NSD1 MCM7 WWTR1 WDR76 HNRNPU UBN1 BRCA1 ATF7IP CTDP1 HTATSF1 ATM CPSF2 | 1.25e-04 | 536 | 184 | 15 | int:POLR2A |
| Interaction | MAGEA9 interactions | 1.29e-04 | 208 | 184 | 9 | int:MAGEA9 | |
| Interaction | ARRDC2 interactions | 1.32e-04 | 54 | 184 | 5 | int:ARRDC2 | |
| Interaction | WWTR1 interactions | TTC28 MPDZ MCM7 WWTR1 ADNP TTF1 ASH2L NEK1 UBA1 SMARCE1 TNKS1BP1 CUX1 PPP6R3 | 1.40e-04 | 422 | 184 | 13 | int:WWTR1 |
| Interaction | PAX6 interactions | ZNF536 SMC1A ZMYM2 ASH2L HNRNPC ZNF462 SALL1 ZFHX4 SMARCE1 TAF1 CUX1 PROX1 | 1.43e-04 | 366 | 184 | 12 | int:PAX6 |
| Interaction | CCP110 interactions | 1.47e-04 | 166 | 184 | 8 | int:CCP110 | |
| Interaction | YWHAB interactions | MAGI1 AKAP8 CALM1 TTC28 POTEF KAT6A ACTB APC WWTR1 INPP5F RFX7 WDR76 LYST RGS12 ITPKB NEK1 TBC1D10B SIPA1L1 NHS FGFR2 SH3RF3 HSPA4 | 1.49e-04 | 1014 | 184 | 22 | int:YWHAB |
| Interaction | SAP30 interactions | 1.53e-04 | 167 | 184 | 8 | int:SAP30 | |
| Interaction | DISC1 interactions | TSR2 CALM1 TRIO SYNM HNRNPC ATF7IP SMARCE1 PRKD1 SPARCL1 DMD NEXN MXD1 PPP6R3 | 1.65e-04 | 429 | 184 | 13 | int:DISC1 |
| Interaction | SIRT7 interactions | DCAF1 USP34 USP9X UGGT1 NSD1 NOL11 MCM7 CHD2 ADNP TTF1 PWP1 MDN1 UTP25 DDX18 TNKS1BP1 ATM HSPA4 PPP6R3 | 1.66e-04 | 744 | 184 | 18 | int:SIRT7 |
| Interaction | ASH2L interactions | SETD1B WWTR1 ASH2L PWP1 BRCA1 ZNF335 BOD1L1 TAF1 HSPA4 PPP6R3 | 1.68e-04 | 265 | 184 | 10 | int:ASH2L |
| Interaction | DENND4A interactions | 1.76e-04 | 90 | 184 | 6 | int:DENND4A | |
| Interaction | MEN1 interactions | SETD1B AKAP8 SMC1A ARFGEF1 ZMYM2 NOL11 ADNP ASH2L HNRNPC ITPR2 PWP1 ZNF462 MDN1 CD2BP2 DDX18 SMARCE1 TNKS1BP1 BOD1L1 TAF1 CPSF2 HSPA4 CUX1 | 1.83e-04 | 1029 | 184 | 22 | int:MEN1 |
| Interaction | GLDC interactions | MAGI1 JCAD AKAP8 UGGT1 ACTB MPDZ HNRNPC HNRNPU SIPA1L1 CPSF2 HSPA4 | 1.85e-04 | 321 | 184 | 11 | int:GLDC |
| Interaction | CHAF1A interactions | SDE2 AKAP8 NRDC USP9X KAT6A ZMYM2 ADNP MDN1 BRCA1 SMARCE1 PPP6R3 | 1.90e-04 | 322 | 184 | 11 | int:CHAF1A |
| Interaction | TEAD2 interactions | 1.94e-04 | 130 | 184 | 7 | int:TEAD2 | |
| Interaction | DYRK2 interactions | 1.95e-04 | 173 | 184 | 8 | int:DYRK2 | |
| Interaction | SH2B1 interactions | 1.98e-04 | 32 | 184 | 4 | int:SH2B1 | |
| Interaction | BRF1 interactions | 1.99e-04 | 92 | 184 | 6 | int:BRF1 | |
| Interaction | GNL1 interactions | 1.99e-04 | 92 | 184 | 6 | int:GNL1 | |
| Interaction | C11orf65 interactions | 2.00e-04 | 13 | 184 | 3 | int:C11orf65 | |
| Interaction | ERG interactions | 2.17e-04 | 223 | 184 | 9 | int:ERG | |
| Interaction | WDR76 interactions | CALM3 SMC1A ACTB MCM7 WDR76 HNRNPC UBA1 MDN1 RLIM SMARCE1 TAF1 CPSF2 | 2.17e-04 | 383 | 184 | 12 | int:WDR76 |
| Interaction | FOXG1 interactions | 2.37e-04 | 95 | 184 | 6 | int:FOXG1 | |
| Interaction | SLX4 interactions | SMC1A ACTB ZMYM2 MCM7 ADNP HNRNPU ZNF462 UBA1 SALL1 MDN1 UBN1 BRCA1 ATF7IP ZNF451 DDX18 | 2.53e-04 | 572 | 184 | 15 | int:SLX4 |
| Interaction | GC interactions | 2.55e-04 | 62 | 184 | 5 | int:GC | |
| Interaction | LHX2 interactions | 2.85e-04 | 183 | 184 | 8 | int:LHX2 | |
| Interaction | TFCP2L1 interactions | 2.96e-04 | 99 | 184 | 6 | int:TFCP2L1 | |
| Interaction | TRIM24 interactions | CALM1 CALM2 CALM3 SMC1A ZMYM2 MCM7 HNRNPC HNRNPU BRCA1 KXD1 ZNF264 TNKS1BP1 | 3.08e-04 | 398 | 184 | 12 | int:TRIM24 |
| Interaction | PLEKHG3 interactions | 3.13e-04 | 100 | 184 | 6 | int:PLEKHG3 | |
| Interaction | MYO10 interactions | 3.19e-04 | 141 | 184 | 7 | int:MYO10 | |
| Interaction | FOXQ1 interactions | 3.19e-04 | 141 | 184 | 7 | int:FOXQ1 | |
| Interaction | SNRNP200 interactions | USP34 USP9X SMC1A KAT6A APC PHAX WDR76 HNRNPC HNRNPU BRCA1 CD2BP2 HTATSF1 BOD1L1 | 3.24e-04 | 460 | 184 | 13 | int:SNRNP200 |
| Interaction | TJP2 interactions | 3.28e-04 | 288 | 184 | 10 | int:TJP2 | |
| Interaction | SMC5 interactions | ZNF143 SMC1A ACTB NSD1 ZMYM2 NOL11 ADNP HNRNPC HNRNPU SALL1 UBN1 BRCA1 ATF7IP DDX18 HTATSF1 SMARCE1 BOD1L1 TAF1 PJA1 TAF1L CUX1 | 3.29e-04 | 1000 | 184 | 21 | int:SMC5 |
| Interaction | SSU72 interactions | 3.42e-04 | 66 | 184 | 5 | int:SSU72 | |
| Interaction | DNAJB2 interactions | 3.48e-04 | 102 | 184 | 6 | int:DNAJB2 | |
| Interaction | LRRK1 interactions | 3.48e-04 | 102 | 184 | 6 | int:LRRK1 | |
| Interaction | CCDC8 interactions | NIBAN1 AKAP8 CALM1 CALM2 CALM3 USP9X SMC1A UGGT1 MCM7 ADNP HNRNPU ITPR2 UBA1 MDN1 STXBP2 HSPA4 | 3.53e-04 | 656 | 184 | 16 | int:CCDC8 |
| Interaction | H2AX interactions | CALM1 CALM2 SMC1A ACTB ZMYM2 GON4L MCM7 ADNP HNRNPC MDN1 BRCA1 RLIM HTATSF1 SMARCE1 ATM | 3.71e-04 | 593 | 184 | 15 | int:H2AX |
| Interaction | PRNP interactions | CCDC14 MAGI1 DMXL2 TRIO KAT6A ZBTB43 CPLX1 APC HNRNPC PPP1R2B NEK1 UBA1 MDN1 UBN1 ZNF451 ZNF335 RLIM GCA PRKD1 SPARCL1 DMD TAF1L HSPA4 | 3.74e-04 | 1158 | 184 | 23 | int:PRNP |
| Cytoband | 2q21.1 | 8.95e-05 | 58 | 184 | 4 | 2q21.1 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.39e-06 | 13 | 123 | 4 | 685 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.34e-05 | 181 | 123 | 8 | 694 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.14e-03 | 115 | 123 | 5 | 769 | |
| Coexpression | GABRIELY_MIR21_TARGETS | CCDC14 USP34 SMC1A UGGT1 APC ARFGEF1 ZMYM2 MPDZ RFX7 ADNP NEK1 TAF1 DMD | 1.46e-07 | 289 | 184 | 13 | M2196 |
| Coexpression | LEE_AGING_MUSCLE_DN | 8.18e-07 | 46 | 184 | 6 | MM670 | |
| Coexpression | GUO_HEX_TARGETS_UP | 1.55e-06 | 80 | 184 | 7 | MM626 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | PRUNE2 CLUAP1 ZBTB16 TIMM23B GON4L CHD2 SLC7A8 MDN1 UBN1 LRP2 NHS DMD FKBP5 CUX1 | 1.63e-06 | 417 | 184 | 14 | M39224 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 4.52e-06 | 176 | 184 | 9 | M39223 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 DMXL2 TTC28 TRIO USP9X KAT6A APC ARFGEF1 ZMYM2 WWTR1 INPP5F ADNP NEK1 MDN1 BRCA1 ZNF451 SIPA1L1 DMD CUX1 | 1.03e-05 | 856 | 184 | 19 | M4500 |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_UP | 1.03e-05 | 195 | 184 | 9 | M8739 | |
| Coexpression | BENPORATH_SOX2_TARGETS | SDE2 CALM2 TIMM23B KAT6A ARFGEF1 REST PHAX HNRNPC PPP1R2 PWP1 TBC1D10B SALL1 STXBP2 ZNF335 NEMF LRP2 FGFR2 | 1.79e-05 | 734 | 184 | 17 | M3835 |
| Coexpression | YAGI_AML_SURVIVAL | 2.68e-05 | 123 | 184 | 7 | M18887 | |
| Coexpression | LEE_BMP2_TARGETS_DN | TSR2 JCAD CASP8AP2 TIMM23B NOL11 TIMM23 ANKRD62 IER5 MCM7 WDR76 PWP1 SLC41A2 MDN1 BRCA1 UTP25 CDCA7 DDX18 HSPA4 FKBP5 | 2.86e-05 | 922 | 184 | 19 | MM1068 |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27 | 3.94e-05 | 10 | 184 | 3 | M3815 | |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | USP34 USP9X TIMM23B TIMM23 INPP5F LYST NEU1 DDX18 ZNF264 FGFR2 | 4.65e-05 | 294 | 184 | 10 | M41112 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | USP34 NIBAN1 CALM1 NRDC CALM3 USP9X KAT6A ACTB NSD1 IER5 CHD2 REST RFX7 FHIP2A LYST HNRNPU ITPKB ITPR2 PCNX2 ATF7IP NEMF SMARCE1 BOD1L1 ATM FKBP5 | 4.85e-05 | 1492 | 184 | 25 | M40023 |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | TTC28 SYNM MPDZ IFIT2 HNRNPU BGN ITPR2 BRCA1 ZFHX4 SPARCL1 FGFR2 | 5.54e-05 | 363 | 184 | 11 | M6315 |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | TTC28 SYNM MPDZ IFIT2 HNRNPU BGN ITPR2 BRCA1 ZFHX4 SPARCL1 FGFR2 | 6.90e-05 | 372 | 184 | 11 | MM1043 |
| Coexpression | BENPORATH_NANOG_TARGETS | CALM2 TIMM23B CNMD KAT6A MPDZ CHD2 REST TTF1 PPP1R2 PWP1 TBC1D10B SALL1 STXBP2 DDX18 NEMF LRP2 HEY2 FGFR2 HSPA4 | 7.20e-05 | 988 | 184 | 19 | M6616 |
| Coexpression | GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP | 7.44e-05 | 195 | 184 | 8 | M10001 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN | 7.71e-05 | 196 | 184 | 8 | M4218 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 7.99e-05 | 197 | 184 | 8 | M9862 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN | 8.57e-05 | 199 | 184 | 8 | M4567 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 8.57e-05 | 199 | 184 | 8 | M6264 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN | 8.87e-05 | 200 | 184 | 8 | M8278 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_12H_BMDC_UP | 8.87e-05 | 200 | 184 | 8 | M3814 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP | 8.87e-05 | 200 | 184 | 8 | M5154 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ACSL6 NOL4 ARPP21 ZBTB43 SYTL2 APC ARFGEF1 RFX7 LYST PNMA8B PTPN5 ZNF462 MDN1 ZFHX4 PHACTR3 SCN8A ZNF264 BOD1L1 GRIP2 CAMTA1 | 1.07e-04 | 1106 | 184 | 20 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | NOL4 ARPP21 ZBTB43 SYTL2 APC PTPN5 CRACD ZFHX4 PHACTR3 SCN8A GRIP2 PROX1 | 1.18e-04 | 465 | 184 | 12 | M39066 |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP | 1.53e-04 | 162 | 184 | 7 | M6673 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.77e-04 | 221 | 184 | 8 | M39222 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_UP | 2.12e-04 | 77 | 184 | 5 | M4263 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP | 2.15e-04 | 17 | 184 | 3 | MM686 | |
| Coexpression | BROWNE_HCMV_INFECTION_14HR_DN | 2.22e-04 | 290 | 184 | 9 | M13251 | |
| Coexpression | GUO_HEX_TARGETS_UP | 2.25e-04 | 78 | 184 | 5 | M1436 | |
| Coexpression | LEE_BMP2_TARGETS_DN | TSR2 JCAD CASP8AP2 NOL11 TIMM23 IER5 MCM7 WDR76 PWP1 SLC41A2 MDN1 BRCA1 UTP25 CDCA7 DDX18 HSPA4 FKBP5 | 2.28e-04 | 904 | 184 | 17 | M2325 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | DCAF1 CASP8AP2 NOL4 ZNF536 ZBTB16 NRDC USP9X SMC1A NSD1 APC ZMYM2 PHAX WDR76 ADNP TTF1 HNRNPU ZNF462 CRACD SALL1 MDN1 BRCA1 NEMF SCN8A KIAA1328 PALM3 SMARCE1 BOD1L1 ATM DMD CPSF2 HSPA4 CUX1 | 6.23e-07 | 1459 | 180 | 32 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | MAGI1 CASP8AP2 DMXL2 ZNF536 USP9X SMC1A ZMYM2 GON4L CHD2 HNRNPU CRACD PPP1R2B NEK1 BRCA1 RNF103 NEMF KXD1 PALM3 BOD1L1 DMD HSPA4 CUX1 | 2.30e-06 | 831 | 180 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | MAGI1 CASP8AP2 SMC1A ZMYM2 CHD2 HNRNPU NEK1 BRCA1 NEMF PALM3 BOD1L1 HSPA4 CUX1 | 2.68e-06 | 311 | 180 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | MAGI1 ACSL6 CASP8AP2 ZNF536 ZBTB16 SMC1A ZMYM2 CHD2 HNRNPU CRACD PPP1R2B NEK1 TRMT10A SALL1 CLCN3 BRCA1 NEMF LRP2 PALM3 BOD1L1 DMD HSPA4 CUX1 PROX1 | 3.48e-06 | 989 | 180 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | DCAF1 CASP8AP2 NRDC USP9X SMC1A NSD1 APC ZMYM2 PHAX WDR76 ADNP TTF1 HNRNPU ZNF462 CRACD MDN1 BRCA1 NEMF SCN8A KIAA1328 SMARCE1 BOD1L1 ATM DMD CPSF2 HSPA4 CUX1 | 7.79e-06 | 1257 | 180 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | MAGI1 CASP8AP2 ZNF536 AKAP8 SMC1A WDR76 HNRNPU BRCA1 NHS DMD HSPA4 PROX1 | 9.55e-06 | 298 | 180 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | MAGI1 CASP8AP2 ZNF536 ZBTB16 ARPP21 AKAP8 SYNM CHD2 HNRNPU PPP1R2B SALL1 MDN1 BRCA1 RTL1 NEMF LRP2 PALM3 NHS DMD SH3RF3 HSPA4 CUX1 RASAL1 | 1.02e-05 | 983 | 180 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | MAGI1 ACSL6 CASP8AP2 ZNF536 PRRX1 ZBTB16 AKAP8 SMC1A WDR76 HNRNPU ZNF462 SALL1 CLCN3 BRCA1 RTL1 LRP2 PALM3 NHS ATM DMD SH3RF3 HSPA4 PROX1 | 1.07e-05 | 986 | 180 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | DCAF1 MAGI1 CASP8AP2 NOL4 ZNF536 USP28 SMC1A NSD1 APC ZMYM2 MCM7 WDR76 HNRNPU ZNF462 CRACD SALL1 BRCA1 SCN8A PALM3 GCA NHS BOD1L1 ATM DMD CAMTA1 HSPA4 CUX1 PROX1 | 1.30e-05 | 1370 | 180 | 28 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SMC1A KAT6A APC ZMYM2 CHD2 REST ADNP IFIT3 HNRNPU PPP1R2B NEK1 CFAP20DC PALM3 BOD1L1 TAF1 DMD HSPA4 | 2.69e-05 | 629 | 180 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | DCAF1 PRRX1 ARPP21 STARD8 SMC1A KAT6A APC ARFGEF1 ZMYM2 MPDZ ADNP HNRNPU ZNF462 PPP1R2B ZFHX4 PALM3 BOD1L1 TAF1 SH3RF3 HSPA4 RASAL1 PPP6R3 | 3.49e-05 | 989 | 180 | 22 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ZNF536 TRIO SMC1A KAT6A APC ARFGEF1 CHD2 INPP5F WDR76 CRACD PPP1R2B NEK1 CFAP20DC SIPA1L1 BOD1L1 TAF1 | 4.96e-05 | 595 | 180 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | CCDC14 ZNF536 ZBTB16 CALM2 CALM3 ACTB WDR76 IFIT2 ZNF462 PPP1R2B SALL1 CLCN3 UTP25 RTL1 NEMF LRP2 PALM3 FGFR2 CPSF2 NEXN SH3RF3 | 1.10e-04 | 994 | 180 | 21 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_100 | 1.25e-04 | 12 | 180 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | MAGI1 CASP8AP2 ZNF536 ZBTB16 AKAP8 WWTR1 CHD2 TTF1 HNRNPU PPP1R2B BRCA1 NEMF NHS DMD HSPA4 CUX1 | 1.49e-04 | 654 | 180 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | DCAF1 CASP8AP2 NOL4 ZNF536 ZBTB16 USP28 SMC1A APC ZMYM2 TTF1 HNRNPU ZNF462 CRACD SALL1 BRCA1 CDCA7 SCN8A LRP2 GCA SMARCE1 BOD1L1 ATM DMD CAMTA1 HSPA4 PROX1 | 1.57e-04 | 1414 | 180 | 26 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.93e-04 | 186 | 180 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#2_top-relative-expression-ranked_500 | 2.27e-04 | 65 | 180 | 5 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.40e-04 | 192 | 180 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#1 | 2.42e-04 | 145 | 180 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.63e-04 | 147 | 180 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | DCAF1 CASP8AP2 USP28 SMC1A APC ZMYM2 TTF1 HNRNPU ZNF462 CRACD BRCA1 CDCA7 SCN8A GCA SMARCE1 BOD1L1 ATM DMD CAMTA1 HSPA4 PROX1 | 2.65e-04 | 1060 | 180 | 21 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 2.74e-04 | 105 | 180 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | DCAF1 TSR2 CASP8AP2 ZNF536 PRRX1 ZBTB16 LPAR4 USP9X SMC1A SYTL2 NSD1 APC ZMYM2 ADNP HNRNPU ITPR2 ZNF462 MDN1 BRCA1 NEMF PALM3 NHS SMARCE1 BOD1L1 NEXN HSPA4 | 2.82e-04 | 1468 | 180 | 26 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 2.85e-04 | 249 | 180 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_100 | 3.09e-04 | 16 | 180 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | CASP8AP2 ZNF536 ZBTB16 SMC1A HNRNPU PPP1R2B SALL1 BRCA1 NEMF LRP2 PALM3 HSPA4 PROX1 | 3.41e-04 | 498 | 180 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_500 | 3.63e-04 | 155 | 180 | 7 | gudmap_kidney_P0_JuxtaGlom_Ren1_k4_500 | |
| CoexpressionAtlas | e10.5_MandibArch_top-relative-expression-ranked_500_2 | 3.73e-04 | 17 | 180 | 3 | Facebase_ST1_e10.5_MandibArch_500_2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | CCDC14 DCAF1 DMXL2 SDE2 USP28 ZBTB43 MCM7 REST WDR76 CFAP20DC TRMT10A MDN1 BRCA1 ZNF451 DDX18 GCA ATM | 4.45e-04 | 795 | 180 | 17 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.09e-04 | 328 | 180 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.27e-04 | 271 | 180 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | DCAF1 SETD1B AKAP8 GON4L CHD2 HNRNPU PCNX2 UTP25 ATF7IP GRAMD1C | 1.96e-09 | 166 | 184 | 10 | 32d2eaf8a5d03881bf74d680825af2d5110b082d |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.96e-09 | 192 | 184 | 10 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 9.23e-09 | 195 | 184 | 10 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-08 | 186 | 184 | 9 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.77e-08 | 189 | 184 | 9 | d69b7a01dd4d6ad043bb6210e9ab34b49578389c | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.77e-08 | 189 | 184 | 9 | 2b5f1b4f173a224342ea4f10b193ee33b7662699 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.77e-08 | 189 | 184 | 9 | 43e131458d8a4b120f7a5fb3d0c5650abded15f6 | |
| ToppCell | Pericytes|World / shred by cell class for parenchyma | 1.33e-07 | 196 | 184 | 9 | 8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.33e-07 | 196 | 184 | 9 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-07 | 198 | 184 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.58e-07 | 200 | 184 | 9 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.36e-07 | 159 | 184 | 8 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.62e-07 | 180 | 184 | 8 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.36e-07 | 182 | 184 | 8 | 728a2152c166551ac229370c0900fe2bc426ea9b | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 9.76e-07 | 183 | 184 | 8 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-06 | 185 | 184 | 8 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-06 | 186 | 184 | 8 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-06 | 187 | 184 | 8 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.29e-06 | 190 | 184 | 8 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-06 | 191 | 184 | 8 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-06 | 192 | 184 | 8 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-06 | 192 | 184 | 8 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-06 | 193 | 184 | 8 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-06 | 193 | 184 | 8 | 800b0f5705fefcd3608e37801afae8a94474723e | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.45e-06 | 193 | 184 | 8 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-06 | 193 | 184 | 8 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 193 | 184 | 8 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 194 | 184 | 8 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 1.51e-06 | 194 | 184 | 8 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 1.51e-06 | 194 | 184 | 8 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 194 | 184 | 8 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-06 | 195 | 184 | 8 | 43d372373367b71243c6ea958aedccde4478618f | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-06 | 196 | 184 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 196 | 184 | 8 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 196 | 184 | 8 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-06 | 196 | 184 | 8 | ce6f7ddb8104471dc90347f427486379914d63b4 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-06 | 196 | 184 | 8 | 6d7179decea512dd49bb2d5f6a4f5989349d52a9 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-06 | 197 | 184 | 8 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-06 | 197 | 184 | 8 | 71367bebc23d0e81f60f780d6b0ab3a1783ac014 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-06 | 197 | 184 | 8 | 0f9836554ace3f9d155ebafdd719aa26466ca44e | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 1.76e-06 | 198 | 184 | 8 | f540f464118edc0fb809ebcb813d0302e6952253 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.83e-06 | 199 | 184 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.83e-06 | 199 | 184 | 8 | 471738f2059e20407572d9c4cbd11812068333ea | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.83e-06 | 199 | 184 | 8 | 706b7de777ff86eb22e538ccd5c2987ceb6be308 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.83e-06 | 199 | 184 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.83e-06 | 199 | 184 | 8 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-06 | 199 | 184 | 8 | 690a4f84b205532c4c9e5c19d5ae430d0655f421 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.83e-06 | 199 | 184 | 8 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.90e-06 | 200 | 184 | 8 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.90e-06 | 200 | 184 | 8 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.90e-06 | 200 | 184 | 8 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.90e-06 | 200 | 184 | 8 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.90e-06 | 200 | 184 | 8 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 154 | 184 | 7 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | metastatic_Brain-Fibroblasts-Smooth_muscle_cells|metastatic_Brain / Location, Cell class and cell subclass | 5.99e-06 | 166 | 184 | 7 | 0da2c6ea1e62f1aafabafbbfbbcc6f7011739346 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.23e-06 | 167 | 184 | 7 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Interneuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 6.28e-06 | 63 | 184 | 5 | c10d344bf32a091deb79e1f128f7dd5e9f4abaa3 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 7.00e-06 | 170 | 184 | 7 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 7.00e-06 | 170 | 184 | 7 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 7.00e-06 | 170 | 184 | 7 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | Pericytes-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 8.45e-06 | 175 | 184 | 7 | ddf721023a7afc8085c5de17aa254a6575444c0f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.45e-06 | 178 | 184 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.80e-06 | 179 | 184 | 7 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.80e-06 | 179 | 184 | 7 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.02e-05 | 180 | 184 | 7 | fb3d549c2a69b2157a486786ddd775ca16699ed0 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.02e-05 | 180 | 184 | 7 | beb4d777e0c5fa0a59672dbc3dbb7732498605ff | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.02e-05 | 180 | 184 | 7 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-05 | 181 | 184 | 7 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.09e-05 | 182 | 184 | 7 | f2a1784ffcba9b27132e0db21e574cbd8a0a6418 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-05 | 182 | 184 | 7 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.09e-05 | 182 | 184 | 7 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-05 | 182 | 184 | 7 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-05 | 182 | 184 | 7 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 183 | 184 | 7 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 184 | 184 | 7 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-05 | 184 | 184 | 7 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 185 | 184 | 7 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 185 | 184 | 7 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 185 | 184 | 7 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 185 | 184 | 7 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 185 | 184 | 7 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.26e-05 | 186 | 184 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-05 | 187 | 184 | 7 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.30e-05 | 187 | 184 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 187 | 184 | 7 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.35e-05 | 188 | 184 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.35e-05 | 188 | 184 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 188 | 184 | 7 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 189 | 184 | 7 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-05 | 189 | 184 | 7 | 979b7fa947538aa7ca4a219263da2575869a2caa | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-05 | 189 | 184 | 7 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 189 | 184 | 7 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | MS-CD8-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 1.44e-05 | 190 | 184 | 7 | 8c831c4560b8e70f92b4c15644fea39f7f7afcf2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 190 | 184 | 7 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-05 | 190 | 184 | 7 | be2b184a3559da41ba387ae0fdbeb9ae532868a5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-05 | 190 | 184 | 7 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.44e-05 | 190 | 184 | 7 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.48e-05 | 127 | 184 | 6 | f808c727c0817ed10e76eaffa9493a516e9a6b50 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-05 | 191 | 184 | 7 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.49e-05 | 191 | 184 | 7 | d4f77c73311d1149466bbfe4adbd6a301946ec90 | |
| Drug | ATP,Gamma S | MYL1 LPAR4 CALM1 CALM2 CALM3 SMC1A APC UBA1 BRCA1 PRKD1 ATM HSPA4 | 4.21e-08 | 189 | 182 | 12 | CID000002028 |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | USP34 SMC1A KAT6A ZBTB43 APC ZMYM2 REST LYST CLCN3 ZNF264 ATM | 4.17e-07 | 191 | 182 | 11 | 4283_DN |
| Drug | NSC366363 | 5.02e-07 | 3 | 182 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 5.02e-07 | 3 | 182 | 3 | CID004630710 | |
| Drug | tatsiensine | 5.02e-07 | 3 | 182 | 3 | CID000163526 | |
| Drug | delcosine | 5.02e-07 | 3 | 182 | 3 | CID000120726 | |
| Drug | Ald1.1-H_000455; Down 200; 10uM; MCF7; HT_HG-U133A | USP34 TTC28 TRIO RFX7 RGS12 HNRNPU ITPR2 CEP72 PLD2 DNAAF1 RASAL1 | 5.97e-07 | 198 | 182 | 11 | 7516_DN |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; PC3; HT_HG-U133A | 5.97e-07 | 198 | 182 | 11 | 7399_DN | |
| Drug | AC1N9TEG | 7.05e-07 | 124 | 182 | 9 | CID000000478 | |
| Drug | indolidan | 1.25e-06 | 11 | 182 | 4 | CID005284402 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.96e-06 | 180 | 182 | 10 | 3688_DN | |
| Drug | Nsc642900 | 2.00e-06 | 4 | 182 | 3 | CID000498959 | |
| Drug | CTK0F9956 | 2.00e-06 | 4 | 182 | 3 | CID011779542 | |
| Drug | 85318-25-8 | 2.00e-06 | 4 | 182 | 3 | CID006439702 | |
| Drug | cloxacepride | 2.00e-06 | 4 | 182 | 3 | CID000068859 | |
| Drug | chloraniformethan | 2.00e-06 | 4 | 182 | 3 | CID000030331 | |
| Drug | Ti 233 | 2.00e-06 | 4 | 182 | 3 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 2.00e-06 | 4 | 182 | 3 | CID000080867 | |
| Drug | herbarumin III | 2.00e-06 | 4 | 182 | 3 | CID000643678 | |
| Drug | thiomethylpromazine | 2.00e-06 | 4 | 182 | 3 | CID000070583 | |
| Drug | KS-504e | 2.00e-06 | 4 | 182 | 3 | CID000129559 | |
| Drug | KS-504d | 2.00e-06 | 4 | 182 | 3 | CID000129557 | |
| Drug | Archanagelicine | 2.00e-06 | 4 | 182 | 3 | CID003083773 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 2.00e-06 | 4 | 182 | 3 | CID000127194 | |
| Drug | Roylin | 2.00e-06 | 4 | 182 | 3 | CID000099924 | |
| Drug | KS-502 | 2.00e-06 | 4 | 182 | 3 | CID000129242 | |
| Drug | KS-501 | 2.00e-06 | 4 | 182 | 3 | CID000129240 | |
| Drug | 2'-methoxykobusin | 2.00e-06 | 4 | 182 | 3 | CID000637889 | |
| Drug | PS-990 | 2.00e-06 | 4 | 182 | 3 | CID000157810 | |
| Drug | AC1L1O6Q | 2.07e-06 | 141 | 182 | 9 | CID000058035 | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.77e-06 | 187 | 182 | 10 | 4323_DN | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | USP34 KAT6A ZBTB43 SYTL2 IFIT2 NEK1 HTATSF1 ZNF264 ATM HSPA4 | 2.90e-06 | 188 | 182 | 10 | 4545_DN |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 3.35e-06 | 191 | 182 | 10 | 5200_DN | |
| Drug | CP-645525-01 [287190-82-3]; Up 200; 10uM; MCF7; HT_HG-U133A | APC ARFGEF1 ZMYM2 HNRNPU CTDP1 PLD2 SLC24A1 GRAMD1C HSPA4 FKBP5 | 3.85e-06 | 194 | 182 | 10 | 7522_UP |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 4.41e-06 | 197 | 182 | 10 | 959_UP | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | USP34 ZBTB43 HNRNPU ITPR2 PCNX2 SLC7A8 SIPA1L1 PLCB3 ATM DNAAF1 | 4.41e-06 | 197 | 182 | 10 | 5576_DN |
| Drug | Vigabatrin [60643-86-9]; Up 200; 31uM; MCF7; HT_HG-U133A | 4.82e-06 | 199 | 182 | 10 | 5415_UP | |
| Drug | jujubogenin | 4.97e-06 | 5 | 182 | 3 | CID005318721 | |
| Drug | D 890 | 4.97e-06 | 5 | 182 | 3 | CID000134083 | |
| Drug | NSC-36360 | 4.97e-06 | 5 | 182 | 3 | CID000133340 | |
| Drug | alpha-CAO | 4.97e-06 | 5 | 182 | 3 | CID000196600 | |
| Drug | AC1NS8P3 | 4.97e-06 | 5 | 182 | 3 | CID005356151 | |
| Drug | 4H-1,4-benzothiazin-3-one | 4.97e-06 | 5 | 182 | 3 | CID000021396 | |
| Drug | Y-acid | 4.97e-06 | 5 | 182 | 3 | CID000007022 | |
| Drug | C16AA | 4.97e-06 | 5 | 182 | 3 | CID000488017 | |
| Drug | auranthine | 4.97e-06 | 5 | 182 | 3 | CID000130919 | |
| Drug | Ant-ATP | 4.97e-06 | 5 | 182 | 3 | CID000134953 | |
| Drug | Nor2 chlorpromazine | 4.97e-06 | 5 | 182 | 3 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 4.97e-06 | 5 | 182 | 3 | CID005748474 | |
| Drug | Ac-dvda | 4.97e-06 | 5 | 182 | 3 | CID000146768 | |
| Drug | VUF 4576 | 4.97e-06 | 5 | 182 | 3 | CID000132784 | |
| Drug | AC1L9KB4 | 5.03e-06 | 15 | 182 | 4 | CID000446969 | |
| Drug | Milrinone [78415-72-2]; Down 200; 19uM; MCF7; HT_HG-U133A | 5.04e-06 | 200 | 182 | 10 | 3552_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 5.04e-06 | 200 | 182 | 10 | 2323_DN | |
| Drug | D-myo-inositol 1,4-bisphosphate | 5.86e-06 | 86 | 182 | 7 | CID000000805 | |
| Drug | fendiline | 6.67e-06 | 16 | 182 | 4 | CID000003336 | |
| Drug | SR 27897 | 8.67e-06 | 17 | 182 | 4 | CID000122077 | |
| Drug | CDP-I | 8.67e-06 | 17 | 182 | 4 | CID000180517 | |
| Drug | ICI D7114 | 8.67e-06 | 17 | 182 | 4 | CID000121877 | |
| Drug | AC1NSV6X | 9.87e-06 | 6 | 182 | 3 | CID005317173 | |
| Drug | N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 9.87e-06 | 6 | 182 | 3 | CID000004307 | |
| Drug | 2,5-diketocamphane | 9.87e-06 | 6 | 182 | 3 | CID000020218 | |
| Drug | benziodarone | 9.87e-06 | 6 | 182 | 3 | CID000006237 | |
| Drug | AC1LCMSV | 9.87e-06 | 6 | 182 | 3 | CID000633347 | |
| Drug | CI-922 | 9.87e-06 | 6 | 182 | 3 | CID000146938 | |
| Drug | caged PE | 9.87e-06 | 6 | 182 | 3 | CID000192405 | |
| Drug | propyl-methylenedioxyindene | 9.87e-06 | 6 | 182 | 3 | CID000145934 | |
| Drug | OPC-18790 | 1.11e-05 | 18 | 182 | 4 | CID000060790 | |
| Drug | myristyl acetate | 1.12e-05 | 63 | 182 | 6 | CID000012531 | |
| Drug | 1-(4-pyridyl)ethanol | 1.72e-05 | 7 | 182 | 3 | CID000090919 | |
| Drug | AC1L52O2 | 1.72e-05 | 7 | 182 | 3 | CID000196983 | |
| Drug | chloronitromethane | 1.72e-05 | 7 | 182 | 3 | CID000074529 | |
| Drug | trifluoperazine sulfoxide | 1.72e-05 | 7 | 182 | 3 | CID000159622 | |
| Drug | DyCl3 | 1.72e-05 | 7 | 182 | 3 | CID000066207 | |
| Drug | DAPpNP | 1.72e-05 | 7 | 182 | 3 | CID005492375 | |
| Drug | T 7188 | 1.72e-05 | 7 | 182 | 3 | CID000003311 | |
| Drug | MS-857 | 1.72e-05 | 7 | 182 | 3 | CID000129517 | |
| Drug | SQ 65442 | 1.72e-05 | 7 | 182 | 3 | CID000128039 | |
| Drug | AC1L3PE4 | 1.72e-05 | 7 | 182 | 3 | CID000093048 | |
| Drug | O-4-(ethoxybutyl)berbamine | 1.72e-05 | 7 | 182 | 3 | CID000188375 | |
| Drug | TZC-5665 | 1.72e-05 | 7 | 182 | 3 | CID006449836 | |
| Drug | KHL-8430 | 1.72e-05 | 7 | 182 | 3 | CID000195711 | |
| Drug | CPU57 | 1.72e-05 | 7 | 182 | 3 | CID000195730 | |
| Drug | Drnflrfamide | 1.72e-05 | 7 | 182 | 3 | CID000132879 | |
| Drug | 4-hydroxyphenylglycol | 1.72e-05 | 7 | 182 | 3 | CID003081980 | |
| Drug | asocainol | 1.72e-05 | 7 | 182 | 3 | CID000071161 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.80e-05 | 184 | 182 | 9 | 1835_DN | |
| Drug | KT5926 | 2.07e-05 | 42 | 182 | 5 | CID000122126 | |
| Drug | KS-619-1 | 2.13e-05 | 21 | 182 | 4 | CID000128369 | |
| Drug | K-259-2 | 2.13e-05 | 21 | 182 | 4 | CID006438946 | |
| Drug | 26 C | 2.13e-05 | 21 | 182 | 4 | CID005327159 | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 2.32e-05 | 190 | 182 | 9 | 2299_DN | |
| Drug | Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.42e-05 | 191 | 182 | 9 | 6776_UP | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; HL60; HT_HG-U133A | 2.52e-05 | 192 | 182 | 9 | 1847_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A | 2.63e-05 | 193 | 182 | 9 | 3667_DN | |
| Drug | proxyl nitroxide | 2.73e-05 | 8 | 182 | 3 | CID000076702 | |
| Drug | niludipine | 2.73e-05 | 8 | 182 | 3 | CID000089767 | |
| Drug | Ro 22-4839 | 2.73e-05 | 8 | 182 | 3 | CID000065839 | |
| Drug | HT-74 | 2.73e-05 | 8 | 182 | 3 | CID000126681 | |
| Drug | 2,6-ANS | 2.73e-05 | 8 | 182 | 3 | CID002762570 | |
| Disease | Intellectual Disability | TRIO NSD1 APC ZMYM2 GON4L FHIP2A HNRNPU ZNF462 BRCA1 ZNF335 RLIM SCN8A LRP2 FGFR2 TAF1 PJA1 | 1.65e-08 | 447 | 179 | 16 | C3714756 |
| Disease | Adenoid Cystic Carcinoma | 2.68e-06 | 100 | 179 | 7 | C0010606 | |
| Disease | Neurodevelopmental Disorders | 2.26e-05 | 93 | 179 | 6 | C1535926 | |
| Disease | intestinal atresia (implicated_via_orthology) | 2.55e-05 | 10 | 179 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 2.55e-05 | 10 | 179 | 3 | C1631597 | |
| Disease | Prostate cancer, familial | 6.38e-05 | 69 | 179 | 5 | C2931456 | |
| Disease | Benign neoplasm of stomach | 1.40e-04 | 17 | 179 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.40e-04 | 17 | 179 | 3 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.40e-04 | 17 | 179 | 3 | C0154060 | |
| Disease | Epilepsy, Cryptogenic | 1.45e-04 | 82 | 179 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 1.45e-04 | 82 | 179 | 5 | C0751111 | |
| Disease | Aura | 1.45e-04 | 82 | 179 | 5 | C0236018 | |
| Disease | Profound Mental Retardation | 2.11e-04 | 139 | 179 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.11e-04 | 139 | 179 | 6 | C0025363 | |
| Disease | Mental deficiency | 2.11e-04 | 139 | 179 | 6 | C0917816 | |
| Disease | response to non-steroidal anti-inflammatory, drug-induced liver injury | 2.18e-04 | 4 | 179 | 2 | EFO_0004228, EFO_0005533 | |
| Disease | Stomach Carcinoma | 2.69e-04 | 21 | 179 | 3 | C0699791 | |
| Disease | Sensorineural Hearing Loss (disorder) | 3.56e-04 | 23 | 179 | 3 | C0018784 | |
| Disease | complement C2 measurement | 3.62e-04 | 5 | 179 | 2 | EFO_0020274 | |
| Disease | Epithelioid hemangioendothelioma | 3.62e-04 | 5 | 179 | 2 | C0206732 | |
| Disease | response to bevacizumab, Proteinuria | 3.62e-04 | 5 | 179 | 2 | EFO_0005943, HP_0000093 | |
| Disease | urate measurement, bone density | CASP8AP2 MYL1 TTC28 HNRNPC ITPKB ITPR2 SLC7A8 SALL1 SCFD1 CPSF2 SH3RF3 RASAL1 | 4.23e-04 | 619 | 179 | 12 | EFO_0003923, EFO_0004531 |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 4.90e-04 | 60 | 179 | 4 | C4722327 | |
| Disease | SPARC-like protein 1 measurement | 5.40e-04 | 6 | 179 | 2 | EFO_0008289 | |
| Disease | Epilepsy | 5.45e-04 | 109 | 179 | 5 | C0014544 | |
| Disease | Bipolar Disorder | 7.06e-04 | 477 | 179 | 10 | C0005586 | |
| Disease | muscular atrophy (biomarker_via_orthology) | 7.14e-04 | 29 | 179 | 3 | DOID:767 (biomarker_via_orthology) | |
| Disease | Phencyclidine-Related Disorders | 7.53e-04 | 7 | 179 | 2 | C0236742 | |
| Disease | Phencyclidine Abuse | 7.53e-04 | 7 | 179 | 2 | C0031391 | |
| Disease | Epileptic encephalopathy | 7.90e-04 | 30 | 179 | 3 | C0543888 | |
| Disease | chemotherapy-induced alopecia, methylcobalamin deficiency type cblE | 1.00e-03 | 8 | 179 | 2 | EFO_0005400, MONDO_0009354 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.00e-03 | 8 | 179 | 2 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.00e-03 | 8 | 179 | 2 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.00e-03 | 8 | 179 | 2 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.00e-03 | 8 | 179 | 2 | DOID:14004 (implicated_via_orthology) | |
| Disease | ovarian cancer (implicated_via_orthology) | 1.00e-03 | 8 | 179 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | Schizophrenia | ANKK1 MAGI1 ACSL6 ACTB CPLX1 APC REST ADNP RGS12 PTPN5 BRCA1 LRP2 FGFR2 ATM | 1.04e-03 | 883 | 179 | 14 | C0036341 |
| Disease | prostate cancer (implicated_via_orthology) | 1.05e-03 | 33 | 179 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 1.30e-03 | 268 | 179 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | breast cancer, ovarian carcinoma | 1.47e-03 | 37 | 179 | 3 | EFO_0001075, MONDO_0007254 | |
| Disease | Cannabis Abuse | 1.59e-03 | 10 | 179 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 1.59e-03 | 10 | 179 | 2 | C0236735 | |
| Disease | Hashish Abuse | 1.59e-03 | 10 | 179 | 2 | C0018614 | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 1.59e-03 | 10 | 179 | 2 | DOID:13832 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 1.66e-03 | 206 | 179 | 6 | C0152013 | |
| Disease | Gastric cancer | 1.94e-03 | 11 | 179 | 2 | cv:C0024623 | |
| Disease | Neoplasm of stomach | 1.94e-03 | 11 | 179 | 2 | cv:C0038356 | |
| Disease | Sensory hearing loss | 1.94e-03 | 11 | 179 | 2 | C1691779 | |
| Disease | GASTRIC CANCER | 1.94e-03 | 11 | 179 | 2 | 613659 | |
| Disease | Malignant neoplasm of breast | STARD8 AKAP8 BGN TRMT10A BRCA1 SIPA1L1 DDX18 HEY2 NHS BOD1L1 FGFR2 ATM PLD2 DMD CUX1 | 2.39e-03 | 1074 | 179 | 15 | C0006142 |
| Disease | age at menopause | 2.55e-03 | 302 | 179 | 7 | EFO_0004704 | |
| Disease | Benign tumor of pancreas | 2.73e-03 | 13 | 179 | 2 | C0347284 | |
| Disease | Adenocarcinoma of large intestine | 2.82e-03 | 96 | 179 | 4 | C1319315 | |
| Disease | cognitive function measurement | MAGI1 USP34 DMXL2 ZNF536 ARPP21 TNFAIP8L3 TTC28 DSPP CNMD CHD2 HNRNPC ATF7IP ZNF335 PHACTR3 PRKD1 DNAH5 SH3RF3 ARAP1 | 2.87e-03 | 1434 | 179 | 18 | EFO_0008354 |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 3.17e-03 | 14 | 179 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | femoral neck bone geometry | 3.17e-03 | 14 | 179 | 2 | EFO_0004511 | |
| Disease | balding measurement | ZNF536 PRRX1 MPDZ BGN ZNF462 UTP25 CDCA7 ATF7IP ANAPC2 PRKD1 HSPA4 CUX1 | 3.39e-03 | 792 | 179 | 12 | EFO_0007825 |
| Disease | Medulloblastoma | 3.49e-03 | 50 | 179 | 3 | C0025149 | |
| Disease | complement factor H-related protein 3 measurement | 3.78e-03 | 169 | 179 | 5 | EFO_0600056 | |
| Disease | mean platelet volume | JCAD NIBAN1 ZBTB16 STARD8 SETD1B NRDC TTC28 REST RGS12 UBN1 CAMTA1 CUX1 MXD1 ARAP1 | 3.87e-03 | 1020 | 179 | 14 | EFO_0004584 |
| Disease | Romano-Ward Syndrome | 4.15e-03 | 16 | 179 | 2 | C0035828 | |
| Disease | thyroid volume | 4.15e-03 | 16 | 179 | 2 | EFO_0004865 | |
| Disease | Leukemia, Myelocytic, Acute | 4.17e-03 | 173 | 179 | 5 | C0023467 | |
| Disease | Metastatic melanoma | 4.34e-03 | 54 | 179 | 3 | C0278883 | |
| Disease | Prostatic Neoplasms | 4.54e-03 | 616 | 179 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.54e-03 | 616 | 179 | 10 | C0376358 | |
| Disease | Mental Depression | 4.68e-03 | 254 | 179 | 6 | C0011570 | |
| Disease | Cannabis Dependence | 4.69e-03 | 17 | 179 | 2 | C0006870 | |
| Disease | Limb Deformities, Congenital | 4.69e-03 | 17 | 179 | 2 | C0206762 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 4.69e-03 | 17 | 179 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 4.69e-03 | 17 | 179 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 4.69e-03 | 17 | 179 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 4.69e-03 | 17 | 179 | 2 | C0751780 | |
| Disease | May-White Syndrome | 4.69e-03 | 17 | 179 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 4.69e-03 | 17 | 179 | 2 | C0751781 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 4.69e-03 | 17 | 179 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Fetal Alcohol Syndrome | 4.69e-03 | 17 | 179 | 2 | C0015923 | |
| Disease | Malignant neoplasm of endometrium | 5.25e-03 | 18 | 179 | 2 | C0007103 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 5.25e-03 | 18 | 179 | 2 | C0751779 | |
| Disease | Carcinoma in situ of endometrium | 5.25e-03 | 18 | 179 | 2 | C0346191 | |
| Disease | Polydactyly | 5.70e-03 | 117 | 179 | 4 | C0152427 | |
| Disease | inosine measurement | 5.85e-03 | 19 | 179 | 2 | EFO_0010503 | |
| Disease | Pancreatic carcinoma | 5.85e-03 | 19 | 179 | 2 | C0235974 | |
| Disease | diet measurement, HOMA-B | 5.85e-03 | 19 | 179 | 2 | EFO_0004469, EFO_0008111 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GMKVEQESSSDDNLE | 511 | Q13523 | |
| GSQVGSEVGADMQES | 296 | Q15361 | |
| NSTIDSEDGEQFDNM | 1066 | Q9H2P0 | |
| SEDGEQFDNMTDGVA | 1071 | Q9H2P0 | |
| SNEDEGSSSEADEMA | 936 | Q9Y5B0 | |
| MNEGDSSLATDLQED | 11 | Q8IYS0 | |
| AEGEVTMETSQAAEG | 686 | Q9Y6Y1 | |
| DSDDESDSGMASQAD | 731 | Q9UJX6 | |
| SDSGMASQADQKEEE | 736 | Q9UJX6 | |
| DMINEVDADGNGTID | 51 | P0DP25 | |
| DGEDSEMQVEAPSDS | 656 | Q9P2I0 | |
| NGAETMAAEAESAQT | 651 | O43823 | |
| SAGSVSEGEEMDTAE | 541 | P39880 | |
| MDDDTAVLVIDNGSG | 1 | Q9BYX7 | |
| VGDMGEGTTINASAD | 341 | Q9Y6D6 | |
| MDDDIAALVVDNGSG | 1 | P60709 | |
| NEDISQELMDSDSGN | 321 | Q8NFD2 | |
| ENFMTVDQDGSGTVE | 126 | P28676 | |
| SNSEQDLEMTSEGEQ | 271 | A6NC57 | |
| DDKSMQGDDPNSSDE | 456 | Q9NZW4 | |
| GAGQQESMEADTDLE | 151 | Q8NAV2 | |
| TAAQDSSAMVGEDVG | 461 | Q9P209 | |
| GDTEADSSNAEEAAM | 1281 | Q8TDJ6 | |
| VVGSQTSDSMGEEDL | 3631 | P11532 | |
| LSVSSGMEGDNEDNE | 736 | Q6ZUJ8 | |
| DMINEVDADGNGTID | 51 | P0DP24 | |
| MAADDDNGDGTSLFD | 1 | Q9UKL3 | |
| QDSDEGSETMALIED | 756 | Q49A88 | |
| MSEQGDLNQAIAEEG | 1 | Q9UBL0 | |
| EGAGDTSEVMDTQAG | 86 | Q9UBL3 | |
| EDSNMDTTLEADTGA | 746 | O95294 | |
| ELDSVMNSENDELNG | 1136 | Q96L73 | |
| ENHAADDSEGGALDM | 11 | P54829 | |
| AMSLVSNEGDSEQNE | 2631 | Q14571 | |
| EEGSIMNGSTAEDEE | 561 | Q0ZGT2 | |
| MNGSTAEDEEQTRSG | 566 | Q0ZGT2 | |
| EQGSREGSESQAEEM | 541 | A6NDB9 | |
| GSGTEEANEDMEEQQ | 501 | Q9UHI5 | |
| IGDDSLQETDVNMES | 511 | Q9H8H0 | |
| DIGASENSDGDMVVS | 296 | P0DJD9 | |
| MVNVTDAISSGDDED | 121 | P21802 | |
| GVTNEKGTDSQAMEE | 436 | Q13451 | |
| ESDMDETIDVGSENN | 11 | Q9UBP5 | |
| MDDDTAVLVIDNGSG | 701 | A5A3E0 | |
| GSDLSDNMSEGSDDS | 1016 | Q13127 | |
| VDGDQEEASGDMEIS | 226 | Q9Y4B6 | |
| MEEGSDDNDSERNSG | 341 | Q15139 | |
| EMDTGADDQDGDAAQ | 4956 | Q9NU22 | |
| ETNVKMESEGGADDS | 246 | P07910 | |
| SDERGSMQSLGSDEG | 186 | Q05195 | |
| EMNSSFTADSGEQEE | 246 | Q96QZ7 | |
| ENKAESEEMETSQAG | 541 | P34932 | |
| ANHSEGQEGSEEADM | 586 | Q96PY6 | |
| GALTAEVGDMTEDSA | 291 | Q9NPP4 | |
| ISEEMEQLDGGDTSS | 691 | O60524 | |
| MKGNEGETESQELSA | 821 | O60721 | |
| EEVSDQTTNNGGELM | 351 | Q99677 | |
| GGADSSDSQDSQQMD | 306 | Q9P266 | |
| EAQAAMEANSEGSLT | 81 | O14810 | |
| DMGLDDTASQQSVSD | 2121 | A6NKB5 | |
| AINGRSQTDDEEMTG | 161 | Q9BQD3 | |
| LEEAGGATSAQIEMN | 1156 | Q9UKX2 | |
| AQDSEQESAGMEGRD | 911 | P07202 | |
| MNDEEASGADTSGVL | 36 | P21810 | |
| ISALDGDQMELGEEN | 96 | Q00839 | |
| GMEESLTTSDGNAES | 161 | Q7L4E1 | |
| SQAMEQEGATAAETE | 191 | P59047 | |
| EEVEALMAGQEDSNG | 166 | P05976 | |
| NDNDCGDGSDEMESV | 2721 | P98164 | |
| SETQNGDVSEETMGS | 36 | Q9NVP1 | |
| MESLKGTGDSVDEQN | 66 | Q86T90 | |
| ETADGESMNTEESNQ | 176 | P41236 | |
| MNKSEDDESGAGELT | 306 | P33993 | |
| DIGASENSDGDMVVS | 296 | P0DJD8 | |
| MSGTNLDGNDEFDEQ | 1 | O43719 | |
| MDDDTAVLVIDNGSG | 701 | Q6S8J3 | |
| DEGTASSEVNATEEM | 576 | Q01970 | |
| DTSVVSEQMAGSEDD | 1381 | Q92794 | |
| QEEQSMDSNLGEAAS | 1356 | P38398 | |
| ESEENGESAMDSTVA | 1821 | Q8NFC6 | |
| SEEEDSLGQTSMSAQ | 141 | O95400 | |
| ETDESQIQMAGGDVE | 86 | Q8WVH0 | |
| DRGEVESMEDDTNGN | 831 | Q13315 | |
| STMAGLEEADAEVSG | 51 | Q8TES7 | |
| GEEEGSEMQIAKSDS | 31 | Q8TD57 | |
| IEMTGEGVDEQQDNS | 246 | O14647 | |
| GGAESEQTVQAMSQD | 16 | Q6ZU35 | |
| SEAMSEVEGLEANEG | 41 | Q99418 | |
| SELEDGSEEMGQGAV | 461 | O14879 | |
| DAGNQLGMEDTSLSS | 66 | Q3T8J9 | |
| LGEDAISSSMEIDQG | 381 | Q6VMQ6 | |
| SDSEANSDEKGIAMN | 166 | Q99698 | |
| MQQADEDSERGLESG | 446 | P09913 | |
| QERGEMTSSDDGENV | 341 | Q8NEP3 | |
| MTSSDDGENVPASAE | 346 | Q8NEP3 | |
| DMINEVDADGNGTID | 51 | P0DP23 | |
| EELSGATGMEQTELE | 211 | Q5W0V3 | |
| INGIATEDGTMEEAN | 511 | Q9C0E4 | |
| GMEGLETAEGSNSES | 216 | Q6IQ49 | |
| GVQSEEEMSEGSQDT | 521 | O00237 | |
| EEMSEGSQDTENDSE | 526 | O00237 | |
| NTGVMDKVQAESDGD | 836 | Q9Y2H2 | |
| DKVQAESDGDMSSDN | 841 | Q9Y2H2 | |
| DVLTNDSSSVGGDME | 896 | Q9NSC2 | |
| SNEDSDSDVEMGENE | 1071 | Q8TE73 | |
| DSTRDEGNETEANSM | 11 | Q5TDP6 | |
| GDMEDGQLSDSDSDM | 6 | Q9H814 | |
| DIGASENSDGDMVVS | 296 | P0DJD7 | |
| NSGEADIMISFENGD | 161 | O60882 | |
| SSADAGENPDEMDQT | 31 | Q96KR7 | |
| SGGEDDDAEEMETGN | 251 | Q5VY09 | |
| QALVDSGADGNFMDE | 426 | A6NKG5 | |
| NGMEDAGDTEEFQSD | 366 | Q9HCH5 | |
| LAIEGTGSDVDDDMS | 1586 | Q93008 | |
| TGSDVDDDMSGDEKQ | 1591 | Q93008 | |
| DDAEMNDEDGGSDVS | 101 | Q68CQ4 | |
| DGKNISMEDDVGESS | 1061 | Q8WUY3 | |
| QEGVDSMAEEGTSDS | 371 | Q969G3 | |
| QEDSAEDTSGAEMTS | 1381 | O15061 | |
| MGSSEQEDGEESPSD | 306 | Q7L5D6 | |
| MQAISEGETENSDGS | 1626 | Q6T4R5 | |
| SDSESEMGPQEATQA | 206 | Q8IZX4 | |
| SDSESEMGPQEATQA | 186 | P21675 | |
| GDKMEDATANGQEDS | 636 | Q9BXS9 | |
| ITDMGTQEDGALEET | 571 | P27987 | |
| LAARENMGSNEGSEE | 491 | Q9ULN7 | |
| NMGSNEGSEEASDEQ | 496 | Q9ULN7 | |
| SENDEDGNLSEDSMR | 266 | Q92786 | |
| SSLATLEGSMDGEEQ | 371 | Q99519 | |
| DLNSKGSLSMDQGDD | 391 | O43166 | |
| GSLSMDQGDDKSNEL | 396 | O43166 | |
| TTAMLQDEDISSDGD | 126 | Q96JW4 | |
| GQQSSGEDMEISDDE | 631 | Q9UPS6 | |
| MDDDTAVLVIDNGSG | 701 | P0CG38 | |
| VEEDMNASAQGASAT | 556 | Q9BVR0 | |
| DRGSEQEDLEDSGSM | 131 | P0DJH9 | |
| MGDSNSDGKTGLEQD | 286 | O94818 | |
| LDSSGNSMNEAEAAG | 451 | Q92502 | |
| EGDSAAEMNGEEEES | 16 | Q9HCU9 | |
| NLLMQSEEVEDSGGA | 56 | Q9UKU0 | |
| MGDTLSEQQLGDSDI | 956 | Q96P48 | |
| LQGSIEDEAMASSGQ | 51 | P25054 | |
| DSNSDSEDESGMNFL | 101 | Q9BWT1 | |
| EAGATESQDSSMEQI | 451 | Q6ZVT6 | |
| GAGVIMDFQTSEDDN | 31 | P51790 | |
| MQGGDSDDNEDSEES | 356 | Q96AJ1 | |
| QDGSMEIDAGNNLET | 86 | O75829 | |
| LSTEMASQDGEEGAS | 206 | O43298 | |
| DDSDGADMIAIGLQE | 451 | Q15735 | |
| DEEETGSPSEDGMQS | 51 | Q13610 | |
| DSDDNMGAKNTSIGE | 1026 | Q9Y4E5 | |
| MEVTATNDGAATDGV | 146 | Q969E8 | |
| SDATTGDEGNTEMES | 2766 | Q86UP3 | |
| ARSMDSDSGEQSEGE | 86 | Q5GJ75 | |
| VADGDNLENMEGVSL | 36 | P52747 | |
| QASDDNDTEATMADG | 126 | Q05516 | |
| NDTEATMADGGAEEE | 131 | Q05516 | |
| TMQTNDDGSLAQEEE | 316 | O14924 | |
| GDTDLAGMSSEQVAQ | 306 | O75970 | |
| SQVSEEQEEMGGQSS | 856 | Q9BZQ8 | |
| EQEEMGGQSSAAQAT | 861 | Q9BZQ8 | |
| ETADGESMNTEESNQ | 176 | Q6NXS1 | |
| AATAAGAGEDMDESS | 36 | Q8TEJ3 | |
| ENSSNEEETSSEGNM | 411 | Q14515 | |
| MENSDSNDKGSGDQS | 1 | Q9NVW2 | |
| SVEQDLAMGSDAEGE | 366 | Q15833 | |
| IGQEEMEASSSQDQS | 796 | Q9C0C2 | |
| ENEESQETAEKGGGM | 11 | A1A519 | |
| SNMEGKTGNTTDDEE | 131 | O43847 | |
| TMDDISQEEGSSQGE | 946 | Q14683 | |
| GEDEGAISMLSDNTA | 366 | Q8WVM8 | |
| SADNLAATDDDGEMN | 981 | Q9UQD0 | |
| DVSSMGSDSEINGLA | 286 | Q4KMP7 | |
| DSDNDDAVRGLGMNN | 1161 | Q2KHR2 | |
| AEDDLNTVAAGTMTG | 151 | Q5SRD1 | |
| MTAELQQDDAAGAAD | 1 | Q96RU2 | |
| GTVVEESNGSDEMEN | 751 | Q96AE7 | |
| ESNGSDEMENSDETK | 756 | Q96AE7 | |
| DFGEEMILTDSNGEQ | 201 | P22314 | |
| SSEDMDSSKGENNDE | 1166 | O15090 | |
| SVNDGQLENTDGRDM | 196 | Q9UBW7 | |
| SQLGQAEDQDGLSEM | 121 | O43296 | |
| SETESEAGDIMDQQF | 1316 | Q96AY4 | |
| AMNLSVDVESSQDGD | 131 | Q9H967 | |
| DMDDGSDSLGVGLDQ | 331 | Q9NPG3 | |
| ELNEIDSENGLSAMD | 391 | Q96JM2 | |
| SMGGDNLSSLDTNEA | 201 | Q6R2W3 | |
| DNQSVRMEEGGSDSD | 291 | Q8TBZ6 | |
| DTEESMQGSSDETAN | 556 | Q70CQ2 | |
| GDMVAAQADENVGEA | 46 | P54821 | |
| MEENEVESSSDAAPG | 1 | Q9H4Z2 | |
| SSSEGDNDSGHELMQ | 471 | Q8NG27 | |
| EAAGSVAMEASSDGE | 766 | Q5H9R7 | |
| TGDELDSSQLQMESD | 11 | O14939 | |
| AEDDLNTVAAGTMTG | 151 | O14925 | |
| NDSEDVDGMQDAGVA | 536 | Q9NYU2 | |
| SMLEGFDENIESQGE | 1471 | O75962 | |
| LSNVDEMDTGENAGQ | 331 | Q9GZV5 |